SB 223: Pupil health: administration of medicinal cannabis: schoolsites.
- Session Year: 2019-2020
- House: Senate
- Latest Version Date: 2019-10-09
|
Date
|
Status
|
|---|---|
| Oct 9, 2019 | Chaptered by Secretary of State. Chapter 699, Statutes of 2019. |
| Oct 9, 2019 | Approved by the Governor. |
| Sep 6, 2019 | Enrolled and presented to the Governor at 2 p.m. |
| Aug 30, 2019 | Assembly amendments concurred in. (Ayes 27. Noes 6.) Ordered to engrossing and enrolling. |
| Aug 26, 2019 | In Senate. Concurrence in Assembly amendments pending. |
| Aug 26, 2019 | Read third time. Passed. Ordered to the Senate. |
| Jun 27, 2019 | Read second time. Ordered to third reading. |
| Jun 26, 2019 | Read second time and amended. Ordered to second reading. |
| Jun 25, 2019 | From committee: Do pass as amended. (Ayes 7. Noes 3.) (June 25). |
| Jun 20, 2019 | From committee: Do pass and re-refer to Com. on JUD. (Ayes 5. Noes 2.) (June 19). Re-referred to Com. on JUD. |
| May 6, 2019 | Referred to Coms. on ED. and JUD. |
| Mar 28, 2019 | In Assembly. Read first time. Held at Desk. |
| Mar 28, 2019 | Read third time. Passed. (Ayes 28. Noes 3.) Ordered to the Assembly. |
| Mar 27, 2019 | Read second time. Ordered to third reading. |
| Mar 26, 2019 | From committee: Do pass. (Ayes 7. Noes 1.) (March 26). |
| Mar 21, 2019 | Set for hearing March 26. |
| Mar 20, 2019 | From committee: Do pass and re-refer to Com. on JUD. (Ayes 6. Noes 0.) (March 20). Re-referred to Com. on JUD. |
| Mar 11, 2019 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on ED. |
| Mar 5, 2019 | Set for hearing March 20. |
| Feb 21, 2019 | Referred to Coms. on ED. and JUD. |
| Feb 8, 2019 | From printer. May be acted upon on or after March 10. |
| Feb 7, 2019 | Introduced. Read first time. To Com. on RLS. for assignment. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 30, 2019 | Unfinished Business SB223 Hill et al. Concurrence | Senate Floor |
Passed |
|
| Aug 26, 2019 | SB 223 Hill Senate Third Reading By Smith | Assembly Floor |
Passed |
|
| Jun 25, 2019 | Do pass as amended. | Assembly Standing Committee on Judiciary |
Passed |
|
| Jun 19, 2019 | Do pass and be re-referred to the Committee on [Judiciary] | Assembly Standing Committee on Education |
Passed |
|
| Mar 28, 2019 | Senate 3rd Reading SB223 Hill et al. | Senate Floor |
Passed |
|
| Mar 26, 2019 | Do pass | Senate Standing Committee on Judiciary |
Passed |
|
| Mar 20, 2019 | Do pass, but first be re-referred to the Committee on [Judiciary] | Senate Standing Committee on Education |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SB 223 |
UNFINISHED BUSINESS
Bill No: SB 223
Amended: 6/26/19
SENATE EDUCATION COMMITTEE: 6-0, 3/20/19
AYES: Leyva, Wilk, Durazo, Glazer, McGuire, Pan
NO VOTE RECORDED: Chang
SENATE JUDICIARY COMMITTEE: 7-1, 3/26/19
AYES: Jackson, Allen, Caballero, Monning, Stern, Umberg, Wieckowski
NOES: Borgeas
SENATE FLOOR: 29-4, 3/28/19
AYES: Allen, Archuleta, Atkins, Beall, Bradford, Caballero, Dodd, Durazo, Galgiani, Glazer, Hill, Hueso, Hurtado, Jackson, Leyva, McGuire, Monning, Moorlach, Pan, Portantino, Roth, Rubio, Skinner, Stern, Stone, Umberg, Wieckowski, Wiener, Wilk
NOES: Borgeas, Grove, Morrell, Nielsen
NO VOTE RECORDED: Bates, Chang, Hertzberg, Jones, Mitchell
ASSEMBLY FLOOR: 43-22, 8/26/19 - See last page for vote
SUBJECT: Pupil health: administration of medicinal cannabis: schoolsites
DIGEST:
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite.
Assembly Amendments
(1) provide definitions for “cannabis” and “cannabis products that are the same as in the California Uniform Controlled Substances Act; (2) revise language relating to pupil records and confidentially to specify that pupil records collected in accordance with the bill shall be treated as medical records; (3) clarify that the governing board of a school district, a county board of education, or the governing body of a charter school may amend, and not just rescind, the policy for any reason at regular meeting; and (4) authorize the governing board of a school district, a county board of education, or the governing body of a charter school to amend or rescind the policy at a special meeting if certain conditions are met.
Existing federal law:
- Classifies “marihuana” as a Schedule I drug. Under federal law, all Schedule I drugs have the following properties:
- “The drug or other substance has a high potential for abuse;”
- “The drug or other substance has no currently accepted medical use in treatment in the United States;” and
- “There is a lack of accepted safety for use of the drug or other substance under medical supervision.” (Title 21, United States Code, § 812(b)(1))
- Defines “marihuana” as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin. Such term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination.” (21 USC § 802(16))
- Requires recipients of federal grants to comply with the Drug-Free Workplace Act, which requires institutions receiving any federal grant to prohibit the manufacture, use and distribution of controlled substances in the workplace. Failure to comply with the Drug-Free Workplace Act is grounds for suspension or termination of the federal grant. (21 USC §§ 8103))
Existing state law:
- Provides, through Proposition 215 of 1996, the Compassionate Use Act, that individuals have the right to obtain and use marijuana for medical purposes where medical use has been deemed appropriate and recommended by a physician because the person’s health would benefit from the use of marijuana in treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief. (Health & Safety Code (HSC) § 11362.5(b)(1)(A))
- Removes the criminal penalties for cultivation and possession of marijuana by qualified patients, who are persons with a physician’s written or oral recommendation or approval to use marijuana for medical use, or by their primary caregivers, and protects physicians from punishment for recommending marijuana to a patient for medical purposes. (HSC § 11362.5(d) and (e))
- Specifies that participation in the Medical Marijuana Program shall not authorize a qualified patient to engage in the smoking of medical marijuana under any of the following circumstances:
- In any place where smoking is prohibited by law;
- In or within 1,000 feet of the grounds of a school, recreation center, or youth center, unless the medical use occurs within a residence;
- On a school bus;
- While in a motor vehicle that is being operated; or
- While operating a boat. (HSC § 11362.79)
- Specifies that, except as authorized by law, a person 18 years of age or older who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs is guilty of a misdemeanor and shall be punished as follows:
- A fine of not more than two hundred fifty dollars ($250), upon a finding that a first offense has been committed.
- A fine of not more than five hundred dollars ($500), or by imprisonment in a county jail for a period of not more than 10 days, or both, upon a finding that a second or subsequent offense has been committed. (HSC § 11357(c))
- Specifies that a person 18 years of age or over who:
- Hires, employs, or uses a minor in unlawfully transporting, carrying, selling, giving away, preparing for sale, or peddling any cannabis, who unlawfully sells, or offers to sell, any cannabis to a minor, or who furnishes, administers, or gives, or offers to furnish, administer, or give any cannabis to a minor under 14 years of age, or who induces a minor to use cannabis in violation of law shall be punished by imprisonment in the state prison for a period of three, five, or seven years.
- Furnishes, administers, or gives, or offers to furnish, administer, or give, any cannabis to a minor 14 years of age or older in violation of law shall be punished by imprisonment in the state prison for a period of three, four, or five years.
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite. Specifically, this bill:
- Authorizes, notwithstanding state law identified in (4) and (5) above, the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt, at a regularly scheduled meeting of the governing board or body, a policy that allows a parent or guardian of a pupil to possess and administer to the pupil who is a qualified patient pursuant to Medicinal Marijuana Program.
- Requires the adopted policy to include at least all of the following elements:
- A prohibition against a parent or guardian from administering medicinal cannabis in a manner that creates a disruption to the educational environment or causes exposure to other pupils.
- A requirement for the parent or guardian to remove any remaining cannabis from the schoolsite after the parent or guardian administers the medicinal cannabis.
- A requirement for the parent or guardian to sign in at the schoolsite before administering the medicinal cannabis.
- A requirement that before administering the medicinal cannabis, the parent or guardian must provide to an employee of the school a valid written medical recommendation for medicinal cannabis for the pupil to be kept on file at the school.
- Provides the following with regards to the pupil records collected in accordance with the adopted policy for the administration of medicinal cannabis to a pupil:
a) Specifies, for purposes of confidentiality and disclosure, that the pupil records shall be treated as medical records and shall be subject to all provisions of state and federal law that govern the confidentiality and disclosure of medical records.
- States legislative findings and declarations that the provisions in (a) impose a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution, and that pursuant to that constitutional provision, that the Legislature finds, to demonstrate the interest protected by this limitation and the need for protecting that interest, that in order to protect the privacy of pupils, and parents and guardians of pupils, who are administered medicinal cannabis, it is necessary that pupil records collected for the purpose of administration of medicinal cannabis be confidential.
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school to amend or rescind the policy at a regularly scheduled meeting of the governing board or body for any reason, including, but not limited to, if the school district, county office of education, or charter school is at risk of, or has lost, federal funding as a result of the policy.
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school to amend or rescind the policy at a special meeting of the governing board or body if both of the following conditions are met:
- Exigent circumstances necessitate an immediate change to the policy.
- At the meeting the governing board or body will address the intent to amend or rescind the policy.
- Specifies that none of the bill’s provisions require the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Provides that “cannabis” and “cannabis products” have the same meaning as in the California Uniform Substance Act.
- Specifies, for purposes of this bill, that medicinal cannabis excludes medicinal cannabis in a smokeable or vapeable form.
Comments
- Need for the bill. According to the author, “Some students need medical cannabis to be able to attend school and have normal childhood experiences. Currently, these students must be picked up by their parents and taken off campus in order to take their medicine. This is disruptive to their learning. Every child is entitled to an uninterrupted education. The Compassionate Use Act of 1996 (Proposition 215) allows minors to use medical cannabis with the consent of their parents and a recommendation from a doctor… Many of these minors need to take a dose of medical cannabis at regular intervals, which often includes during school hours. Current law does not allow any form of cannabis on school grounds. Existing law allows schools to legally administer any pharmaceutical drug, including opioids, that a child has been prescribed. But there are medical conditions pharmaceuticals can’t fix, and they often have debilitating side effects. Medical cannabis helps fill some of these gaps, and lessen these challenging side effects.”
- Potential for medical benefits from medicinal cannabis. On July 25, 2018, the United States Food and Drug Administration (FDA) approved Epidiolex, the drug used in the trial published in The Lancet, as an oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. According to the FDA, “it is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA-approval of a drug for the treatment of patients with Dravet syndrome.” In its announcement of the approval, the FDA stated that “Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo.”
- Other states have recently approved similar measures. In 1996, California became the first state to approve medical marijuana. According to the National Conference of State Legislatures, since then, an additional 28 states, the District of Colombia, Guam, and Puerto Rico have followed suit and now allow for comprehensive public medical marijuana programs. An additional 17 states allow the use of “low THC, high cannabidiol (CBD)” for medical reasons or as a legal defense.
More recently, five of the 29 states with comprehensive medical marijuana programs: Washington, Colorado, Florida, Maine, and New Jersey have enacted laws authorizing students to use medical cannabis on school campuses. According to the Education Commission of the States, “While it is too soon to identify specific trends in policies, both New Jersey and Colorado require that:
- Students using medicinal marijuana products have a valid medical recommendation.
- Only non-smokeable marijuana products may be administered on school grounds.
- Only parents, legal guardians or primary caregivers administer the substance.
d) Students cannot be punished for marijuana use on school grounds.”
Maine’s law differs from those states because policymakers worked from the state’s existing medical marijuana framework and simply expanded the locations in which medical marijuana use is permissible. Alternatively, Washington has taken a slightly different path and instead specifies that schools are not required to permit on-site use of medical marijuana, but are permitted to allow it if they choose. Conversely, Florida requires each district school board to adopt a policy and procedure. Additionally, earlier this year New Mexico authorized students to receive medicinal marijuana on school campuses.
Related/Prior Legislation
SB 1127 (Hill, 2018) was identical to this bill and was vetoed by Governor Brown, who stated:
“This bill is overly broad as it applies to all students instead of limited cases where a doctor recommends medical marijuana for a student in order to prevent or reduce the effects of a seizure. Generally, I remain concerned about the exposure of marijuana on youth and am dubious of its use for youth for all ailments. This bill goes too far -- further than some research has -- to allow use of medical marijuana for youth. I think we should pause before going much further down this path.”
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
Americans for Safe Access
California Cannabis Industry Association
California Health Coalition Advocacy
California NORML
California School Boards Association
CannaKids
Rincon Valley Union School District
Southern California Coalition
United Cannabis Business Association
Numerous individuals
OPPOSITION: (Verified 8/27/19)
None received
ASSEMBLY FLOOR: 43-22, 8/26/19
AYES: Aguiar-Curry, Bauer-Kahan, Berman, Bloom, Bonta, Burke, Carrillo, Chau, Chiu, Cooley, Daly, Frazier, Friedman, Gabriel, Cristina Garcia, Eduardo Garcia, Gipson, Gloria, Grayson, Holden, Jones-Sawyer, Kalra, Kamlager-Dove, Lackey, Levine, Limón, Low, McCarty, Mullin, Nazarian, O'Donnell, Quirk, Reyes, Luz Rivas, Robert Rivas, Blanca Rubio, Santiago, Smith, Mark Stone, Ting, Wicks, Wood, Rendon
NOES: Bigelow, Boerner Horvath, Brough, Cervantes, Choi, Flora, Fong, Gallagher, Gray, Irwin, Kiley, Maienschein, Mathis, Mayes, Medina, Obernolte, Patterson, Petrie-Norris, Quirk-Silva, Ramos, Salas, Voepel
NO VOTE RECORDED: Arambula, Calderon, Chen, Chu, Cooper, Cunningham, Diep, Eggman, Gonzalez, Melendez, Muratsuchi, Rodriguez, Waldron, Weber
Prepared by: Brandon Darnell / ED. /
8/29/19 11:35:51
SENATE THIRD READING
STR Bill Id:SB 223
Author:(Hill)
As Amended Ver:June 26, 2019
Majority vote
SUMMARY:
Authorizes the governing board of a school district, a county board of education, and the governing body of a charter school maintaining kindergarten or any of grades one to 12 to adopt a policy that allows a parent or guardian to possess and administer non-smokeable and non-vapeable medicinal cannabis to an authorized pupil at a schoolsite, if that pupil is a qualified patient pursuant to the Medical Marijuana Program.
Major Provisions
- Authorizes, notwithstanding other state law, the governing board of a school district, a county board of education, and the governing body of a charter school maintaining kindergarten or any of grades one to 12, inclusive, to adopt, at a regularly scheduled meeting of the governing board or body, a policy that allows a parent or guardian to possess and administer medicinal cannabis to a pupil at a schoolsite, if the pupil is a qualified patient pursuant to the Medical Marijuana Program.
- Requires the adopted policy to include, but not be limited to, all of the following elements:
- Prohibits a parent or guardian from administering the medicinal cannabis in a manner that creates a disruption to the educational environment or causes exposure to other pupils;
- Requires the parent or guardian to remove any remaining cannabis from the schoolsite after the parent or guardian administers the medicinal cannabis to the pupil;
- Requires the parent or guardian to sign in at the schoolsite before administering the medicinal cannabis; and
- Requires the parent or guardian to provide, to an employee of the school, a valid written medical recommendation for medicinal cannabis for the pupil, and requires that the school keep the recommendation on file at the school.
- Requires pupil records collected in accordance with the provisions of this section to be treated as medical records and be subject to all provisions of state and federal law governing confidentiality and disclosure of medical records.
- Authorizes the governing board or body to amend or rescind the policy for any reason, including, but not limited to, the potential loss of federal funding as a result of the policy.
- States that none of the bill's provisions require the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Defines "cannabis" and "cannabis products," for purposes of this section, as those terms are defined in Health and Safety Code, and specifies that "medicinal cannabis" excludes medicinal cannabis or cannabis products in a smokeable or vapeable form.
COMMENTS:
In 1996, California passed the Compassionate Use Act, making it the first state to decriminalize the medicinal use of cannabis for the treatment of a variety of ailments. However, the federal government designates cannabis as a Schedule I substance, defined as having a substance with a high potential for abuse, lacking an accepted medical use, and lacking accepted safety for use in treatment under medical supervision. Contrary to this designation, an extensive body of scientific research supports the efficacy of cannabis for the treatment of a number of maladies.
Current California law prohibits the possession and use of cannabis within 1,000 feet of a schoolsite. Since the pediatric conditions most effectively treated by cannabis require regular treatment, however, the burdens of this restriction may result in a significant impediment to a child’s education. Under current law, parents and guardians of pupils carrying valid medicinal cannabis recommendations must pull their children out of class, check them out of school, drive them more than 1,000 feet from school grounds, administer medication, drive them back to the school, and check them back in. This bill seeks to facilitate the prompt and unobtrusive administration of medicinal cannabis to students in need of such treatment.
According to the Author:
"SB 223 will help students with severe medical disabilities attend school. The only medication that works for some of these students is medical cannabis. This bill will allow a parent to come on campus to administer medical cannabis to them in non-smoking and non-vaping forms."
Arguments in Support:
The California School Boards Association states, "The Individuals with Disabilities Education Act (IDEA) requires schools to provide accommodations for all children to attend school. Since it’s against the law for kids to take medical cannabis on campus at public schools, some school districts must pay for these students to go to private school, where it can be administered on campus. As the uses of medical cannabis have expanded, doctors are recommending its use to address a variety of issues. Some students need medical cannabis to be able to attend school and have normal childhood experiences. Currently, these students must be picked up by their parents and taken off campus in order to take their dosage. This is disruptive to their learning. Every child is entitled to an uninterrupted education. This bill allows the medical needs of students to be addressed to ensure they receive an appropriate education."
Arguments in Opposition:
The California Police Chiefs Association states, "One of law enforcements top priorities is to prevent any youth under the age of 21 from accessing all types of cannabis products. While we understand some parents may choose to treat their student’s illnesses with cannabis, we are opposed to allowing parents or guardians administer the drug to their student while on school grounds. We are concerned this exemption would be exploited which could jeopardize the safety of the other students. For these reasons, we must oppose this measure."
FISCAL COMMENTS:
This bill has been keyed non-fiscal by the Office of Legislative Counsel.
VOTES:
SENATE FLOOR: 29-4-5
YES: Allen, Archuleta, Atkins, Beall, Bradford, Caballero, Dodd, Durazo, Galgiani, Glazer, Hill, Hueso, Hurtado, Jackson, Leyva, McGuire, Monning, Moorlach, Pan, Portantino, Roth, Rubio, Skinner, Stern, Stone, Umberg, Wieckowski, Wiener, Wilk
NO: Borgeas, Grove, Morrell, Nielsen
ABS, ABST OR NV: Bates, Chang, Hertzberg, Jones, Mitchell
ASM EDUCATION: 5-2-0
YES: O'Donnell, Kalra, McCarty, Smith, Weber
NO: Kiley, Voepel
ASM JUDICIARY: 7-3-2
YES: Mark Stone, Chau, Chiu, Gonzalez, Holden, Kalra, Reyes
NO: Gallagher, Kiley, Obernolte
ABS, ABST OR NV: Maienschein, Petrie-Norris
UPDATED:
VERSION: June 26, 2019
CONSULTANT: Debbie Look / ED. / (916) 319-2087 FN: 0001160
Date of Hearing: June 25, 2019
ASSEMBLY COMMITTEE ON JUDICIARY
Mark Stone, Chair
SBPCA Bill Id:SB 223
Author:(Hill) – As Amended Ver:March 11, 2019
As Proposed to be Amended
SENATE VOTE: 29-4
SUBJECT: PUPIL HEALTH: ADMINISTRATION OF MEDICINAL CANNABIS: SCHOOLSITES
KEY ISSUE: SHOULD A PARENT OR GUARDIAN OF A CHILD WHO IS PRESCRIBED MEDICINAL CANNABIS BE PERMITTED TO possess and ADMINISTER CANNABIS TO THE child ON SCHOOL PREMISES?
SYNOPSIS
In 1996, California passed the Compassionate Use Act, making it the first state to decriminalize the medicinal use of cannabis for the treatment of a variety of ailments. However, the effective legalization of medicinal cannabis in California stands at odds with the federal designation of cannabis as a Schedule I substance, defined as having a substance with a high potential for abuse, lacking an accepted medical use, and lacking accepted safety for use in treatment under medical supervision. Contrary to this designation, an extensive body of scientific research supports the efficacy of cannabis for the treatment of a number of maladies. For example, there is strong, conclusive evidence to support therapeutic utility for cannabis in the treatment of some treatment-resistant forms of epilepsy and for chemotherapy-induced nausea and vomiting in children. These pediatric uses must be weighed against evidence that childhood and adolescent cannabis exposure can affect cognitive development. Still, compared to the debilitating symptoms of these conditions and the possible developmental risks associated with, for instance, frequent prolonged seizures, pediatric cannabis use is quite often the lesser of two evils.
Current California law prohibits the possession and use of cannabis within 1,000 feet of a schoolsite. Since the pediatric conditions most effectively treated by cannabis require regular treatment, however, the burdens of this restriction can accumulate to a significant impediment to a child’s education. Under current law, parents and guardians of pupils carrying valid medicinal cannabis recommendations must pull their children out of class, check them out of school, drive them more than 1,000 feet from school grounds, administer medication, drive them back to the school, and check them back in.
This bill seeks to facilitate the prompt and unobtrusive administration of medicinal cannabis to students in need of such treatment. The bill permits local school governing bodies to adopt policies that allow a parent or guardian to administer medical cannabis to a pupil with a valid physician’s recommendation on school grounds, and to rescind those policies at any regularly scheduled meeting of the body. The bill specifies that such a policy must include several requirements for such administration, including that administration must be in a manner that does not disrupt the educational environment or expose other pupils, that any remaining medical cannabis is removed from the schoolsite by the parent or guardian, that the parent or guardian signs in at the schoolsite before administration, and that the parent or guardian provides a valid written medical recommendation to be kept on file at the school. The bill in print also significantly restricts access to school records associated with administration of medical cannabis to a pupil. Importantly, the bill does not require a school district to permit medical cannabis on school grounds, but simply provides the option for a school district to do so. Though there is some concern that such a policy may jeopardize federal funding for schools due to the federal prohibition on cannabis, it is unlikely that funding would be revoked on such grounds, and the bill anticipates this risk by allowing for the policy to be promptly rescinded if necessary. A bill identical to the bill in print, SB 1127, was vetoed by Governor Brown in 2018, citing concern over youth exposure to cannabis.
The author has prudently accepted amendments to clarify that the records kept by a school related to medicinal cannabis administration shall be treated as medical records for the purposes of confidentiality and disclosure, and to permit a governing body to, if exigent circumstances necessitate, repeal or amend a policy pursuant to this provision at a special meeting of the body. The author has also accepted a technical amendment to clarify that the definition of cannabis includes cannabis products. These proposed amendments are reflected in the analysis.
This bill is supported by several cannabis advocacy groups, as well as the California School Boards Association, and the San Mateo and Rincon Valley School Districts. Supporters argue that this bill is essential to providing an educational environment conducive to learning for students in need of medical cannabis. The bill is opposed by the California Police Chiefs Association, who voice concern regarding the possible exposure of children to cannabis. This bill passed out of the Assembly Committee on Education on a 5-2, party-line vote.
SUMMARY: Permits the governing board of a school district, a county board of education, or the governing body of a charter school to adopt a policy allowing a parent or guardian of a pupil who is a qualified medicinal cannabis patient to possess and administer medicinal cannabis to that pupil at a schoolsite. Specifically, this bill:
- Permits the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil who is a qualified medicinal cannabis patient to possess and administer medicinal cannabis to that pupil at a school site.
- Requires any policy established pursuant to 1) to include, at a minimum, all of the following elements:
- That the parent or guardian shall not administer the medicinal cannabis in a manner that disrupts the educational environment or exposes other pupils.
- That after the parent or guardian administers the medicinal cannabis, the parent or guardian shall remove any remaining medicinal cannabis from the schoolsite.
- That the parent or guardian shall sign in at the schoolsite before administering the medicinal cannabis.
- That before administering the medicinal cannabis, the parent or guardian shall provide to an employee of the school a valid written medical recommendation for medicinal cannabis for the pupil to be kept on file at the school.
- Provides that, for purposes of confidentiality and disclosure, pupil records collected in accordance with a policy adopted pursuant to 1) and 2) for the purpose of administering medicinal cannabis to a pupil shall be treated as medical records, and shall be subject to all provisions governing the confidentiality and disclosure of medical records under state and federal law.
- Provides that the governing body or board that adopts a policy pursuant to 1) may amend or rescind the policy at a regularly scheduled meeting of that board or body for any reason, including, but not limited to, if the school district, county office of education, or charter school is at risk of, or has lost, federal funding as a result of the policy.
- Provides that the governing body or board that adopts a policy pursuant to 1) may amend or rescind the policy at an emergency meeting of that board or body, provided the following conditions are met:
- Exigent circumstances necessitate an immediate change to the adopted policy.
- The governing board or body provides public notice at least 10 days in advance of the emergency meeting and that notice includes, at minimum, the time, the date, and the location of the meeting, and that the meeting will address the intent to amend or rescind the policy.
- Specifies that nothing in the bill requires the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Provides that, for the purposes of this measure, “cannabis” includes cannabis products.
- Provides that, for the purposes of this measure, “cannabis” means all parts of the plant Cannabis sativa L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin, but does not include industrial hemp or the weight of any other ingredient combined with cannabis to prepare topical or oral administrations, food, drink, or other product.
- Provides that, for the purposes of this measure, “cannabis products” means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.
- Provides that, for the purposes of this measure, “medicinal cannabis” excludes medicinal cannabis or cannabis products in a smokeable or vapeable form.
- Makes a legislative finding and declaration as to the interest protected by limiting public access to public records produced in accordance with this measure.
EXISTING LAW:
- Provides, under federal law, that “marihuana” is a "Schedule 1" drug (with no safe use recognized by law), and thus a controlled substance subject to federal prohibitions. (21 U.S.C. Section 812.)
- Prohibits, under federal law, any person from knowingly or intentionally possessing a controlled substance unless such substance was obtained directly, or pursuant to a valid prescription or order, from a practitioner, while acting in the course of his professional practice. (21 U.S.C. Section 844 (a).)
- Provides, under federal law, that no funds appropriated to the Department of Justice may be used to prevent states who have adopted laws that authorize the use, distribution, possession, or cultivation of medicinal marijuana from implementing those laws. (Consolidated Appropriations Act, 2019, 116 P.L. 6, Section 537.)
- Requires, under federal law, that recipients of federal grants comply with the Drug-Free Workplace Act, which requires institutions receiving any federal grant to prohibit the manufacture, use, and distribution of controlled substances in the workplace. Failure to comply with the Drug-Free Workplace Act is grounds for suspension or termination of the federal grant. (21 U.S.C. Section 8103.)
- Permits individuals to obtain and use cannabis for medical purposes where medical use has been deemed appropriate and recommended by a physician for the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which cannabis provides relief. (Health & Safety Code Section 11362.5.)
- Removes the criminal penalties for cultivation and possession of cannabis by qualified patients, who are persons with a physician’s written or oral recommendation or approval to use cannabis for medical use, or by their primary caregivers, and protects physicians from punishment for recommending cannabis to a patient for medical purposes. (Health & Safety Code Section 11362.5.)
- Specifies that the qualified patients may not smoke cannabis in places where smoking is otherwise prohibited or use cannabis in certain contexts, including within 1,000 feet of school grounds or while operating a vehicle. (Health & Safety Code Section 11362.79.)
- Specifies that, except as authorized by law, a person 18 years of age or older who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs is guilty of a misdemeanor. (Health & Safety Code Section 11357.)
FISCAL EFFECT: As currently in print this bill is keyed non-fiscal.
COMMENTS: In 1996, California passed the Compassion Use Act, making it the first state to decriminalize the medicinal use of cannabis for the treatment of a variety of ailments. However, the effective legalization of medicinal cannabis in California stands at odds with the federal designation of cannabis as a Schedule I substance, defined as a substance having a high potential for abuse, lacking an accepted medical use, and lacking accepted safety for use in treatment under medical supervision. Contrary to this designation, an extensive body of scientific research supports efficacy for cannabis in the treatment of a number of maladies. For example, there is strong, conclusive evidence to support therapeutic utility for cannabis in the treatment of some treatment-resistant forms of epilepsy and chemotherapy-induced nausea and vomiting in children. These pediatric uses must be weighed against evidence that childhood and adolescent cannabis exposure can affect cognitive development. Still, compared to the debilitating symptoms of these conditions and the possible developmental risks associated with, for instance, frequent prolonged seizures, pediatric cannabis use is quite often the lesser of two evils.
Current California law prohibits the possession and use of cannabis within 1,000 feet of a schoolsite. Since the pediatric conditions most effectively treated by cannabis require regular treatment, however, the burdens of this restriction can accumulate to become a significant impediment to a child’s education. Under current law, parents and guardians of pupils carrying valid medicinal cannabis recommendations must pull their children out of class, check them out of school, drive them more than 1,000 feet from school grounds, administer the medication, drive them back to the school, and check them back in.
This bill seeks to facilitate the prompt and unobtrusive onsite administration of medicinal cannabis to students in need of such treatment. The bill permits local school governing bodies to adopt policies that allow a parent or guardian to administer medical cannabis to a pupil with a valid physician’s recommendation on school grounds, and to rescind those policies at any regularly scheduled meeting of the body. The bill specifies that such a policy must include several constraints on such administration in order to ensure that students are not unnecessarily exposed to cannabis, including that administration must be in a manner that does not disrupt the educational environment or expose other pupils, that any remaining medical cannabis is removed from the schoolsite by the parent or guardian, that the parent or guardian signs in at the schoolsite before administration, and that the parent or guardian provides a valid written medical recommendation to be kept on file at the school. The bill in print also significantly restricts access to school records associated with the administration of medical cannabis to a pupil. Importantly, the bill does not require a school district to permit medical cannabis on school grounds, but simply provides a school district with the option to do so. Though there is some concern that such a policy may jeopardize federal funding due to the federal prohibition on cannabis, it is unlikely that funding would be revoked on such grounds, and the bill anticipates this risk by allowing for the policy to be promptly rescinded.
The author has prudently accepted amendments to clarify that the records kept by a school related to medicinal cannabis administration must be treated as medical records for the purposes of confidentiality and disclosure, and to permit a governing body, if exigent circumstances necessitate, to repeal or amend a policy pursuant to this provision at a special meeting of the body. The author has also accepted a technical amendment to clarify that the definition of cannabis includes cannabis products.
According to the author:
Many…minors need to take a dose of medical cannabis at regular intervals, which often occur during school hours. Current law does not allow any form of cannabis on school grounds. Existing law allows schools to legally administer any pharmaceutical drug, including opioids, that a child has been prescribed. But there are medical conditions pharmaceuticals can’t fix, and they often have debilitating side effects. In some of these cases, medical cannabis is highly effective.
Under current law, students who have a medical cannabis recommendation must be picked up by their parent, signed out of school, and taken 1000 feet off campus to receive their medication. A parent in our district estimates that by the end of the school year, her Kindergartener will have lost over 100 hours of educational time, all to receive his doctor-recommended treatment.
SB 223 will allow a parent or guardian to administer medical cannabis to their child on school grounds in a non-smoking and non-vaping form. The child must be a qualified medical cannabis patient with a doctor’s recommendation. Usually the medicine is administered as oil, capsules, tinctures, liquids, or topical creams. The bill also requires that a parent must give the school a copy of their child’s medical cannabis recommendation to keep on file, sign in when they come on campus to administer the medicine, not disrupt the educational environment, and take all cannabis from school grounds after administration.
SB 223 will allow K-12 school districts and county boards of education to choose whether to opt-in. It is not a state mandate. Districts and counties that opt-in can opt-out for any reason, including if federal funding is put at risk as a result of this policy.
Proposition 215, the Compassionate Use Act, permitted the medical recommendation, possession, and use of cannabis in California. In 1996, California voters approved Proposition 215, which effectively decriminalized the medicinal use of cannabis in the state. The measure declared that no physician who recommended cannabis to a patient for a legitimate medical purpose would be subject to professional discipline or punished under state law, and permitted the possession, cultivation, and use of cannabis for medicinal purposes by any person who possessed a physician’s written recommendation for medical cannabis. Though Proposition 215 produced a “limited ‘immunity’ defense to prosecution under state law for the cultivation or possession of marijuana,” it did not preclude arrest on the grounds of such possession or cultivation.
To resolve practical issues relating to the scope and application of the provisions created by Proposition 215, the California Senate passed SB 420, the Medical Marijuana Program Act (MMPA), in 2003. The MMPA, inter alia, created the voluntary Medical Marijuana Identification Card Program to “facilitate the prompt identification of qualified patients and their designated primary caregivers in order to avoid unnecessary arrest and prosecution,” recognized the rights of patients and caregivers to form collectives or cooperatives for the cultivation of medical marijuana, and prohibited cannabis smoking in areas in which smoking is prohibited, within 1,000 feet of a school or youth center, on school buses, in a motor vehicle that is being operated, or while operating a boat. (Health & Safety Code Section 11362.7 et seq.) In doing so, the MMPA, through the creation of the ID program, provided a means to protect against arrest on the grounds of lawful medicinal use, possession, or cultivation of cannabis, and established legislative intent to develop a regulatory apparatus encompassing the medicinal cannabis program.
In 2016, California voters expanded the scope of cannabis consumption considered lawful under state law by approving Proposition 64, which legalized the possession of small amounts of cannabis for recreational use for adults 21 years of age or older. (Health & Safety Code Section 11357.) Proposition 64 limited recreational cannabis consumption to private residences or designated businesses, maintaining prohibitions on public consumption as well as operation of a vehicle under the influence of cannabis. Importantly, Proposition 64 did not permit possession of cannabis on the grounds of a school, daycare center, or youth center while children are present, but expressly exempted from these limitations any possession allowed by the Compassionate Use Act, stating:
Nothing in this section shall be construed or interpreted to amend, repeal, affect, restrict, or preempt laws pertaining to the Compassionate Use Act of 1996. (Health & Safety Code Section 11362.3(c).)
Cannabis remains illegal, including for medical use, under federal law. Proposition 215 was the first act by a state that expressly permitted the medicinal use of cannabis, and it launched a slew of legal disputes over conflicts between this state law and the federal prohibition of marijuana under the Controlled Substances Act (CSA). With the passage of Proposition 64 and the recreational or medicinal legalization of cannabis in 33 states and the District of Columbia, the boundaries of state authority to regulate the consumption, cultivation, and possession of cannabis for recreational and medicinal purposes continue to be litigated.
Specifically, the CSA classifies “marihuana” and “tetrahydrocannabinols, except for tetrahydrocannabinols in hemp” as Schedule I substances, meaning the following criteria are considered to apply:
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision. (21 U.S.C. Section 812.)
This strict classification is largely a legislative relic resulting from the sociopolitical climate at the time in the late 1960s, when the CSA was drafted. The CSA was signed into law in 1970 by President Richard Nixon as the “hippie” countercultural movement, which in part championed recreational drug use, continued to grow. On its signing, marijuana was classified temporarily as a Schedule I substance pending further review, consistent with several decades of stigmatization and criminalization rooted in associations between the consumption of marijuana and minority communities, primarily black and Latino. Indeed, the term “marihuana” used in the CSA is itself a racialized moniker intended to entangle public perception of the substance with anti-immigrant sentiment. (Brent Staples, The Federal Marijuana Ban Is Rooted in Myth and Xenophobia, The New York Times, Jul. 29, 2014, https://www.nytimes.com/2014/07/30/opinion/high-time-federal-marijuana-ban-is-rooted-in-myth.html.) Two years later, the National Commission on Marihuana and Drug Abuse, also known as the Shafer Commission, issued a series of reports questioning the appropriateness of the temporary Schedule I classification. The Shafer Commission suggested rather unequivocally that possession of small quantities of marijuana should be federally decriminalized because evidence supported that it was neither as dangerous nor as addictive as had been previously suggested. (John Hudak, How racism and bias criminalized marijuana, The Washington Post, Apr. 28, 2016, https://www.washingtonpost.com/news/in-theory/wp/2016/04/28/how-racism-and-bias-criminalized-marijuana/.) Nonetheless, President Nixon rejected the recommendation of the Commission in a decision that was, based on the testimony of Nixon’s aides and on transcripts of Oval Office tapes, likely motivated by animus against Jews, blacks, and hippies. (Ibid.)
Though the CSA permits the Drug Enforcement Agency (DEA) to reclassify drugs to less restrictive schedules in response to petitions, all such petitions, the most recent of which was filed in 2011, have thus far been denied. (See Americans for Safe Access v. DEA (2013) 706 F.3d 438.) The Schedule I classification of cannabis has served as a significant impediment to research on the medicinal properties of cannabis, and has further complicated the implementation of state measures legalizing medical and recreational cannabis use due to preemption and federal enforcement concerns.
Legitimate medicinal uses of cannabis are supported by a wide body of scientific literature. Contrary to this federal designation, a substantial body of scientific evidence supports the medical utility of cannabis across a range of maladies. It should be noted that cannabis, as defined, contains a plethora of psychoactive and non-psychoactive constituent chemicals that may or may not contribute to therapeutic efficacy for a given condition. Federal prohibitions have made it difficult to study the medicinal promise of cannabis generally, and consequently, most clinical research investigates therapeutic potential of specific cannabis constituents or derivatives. Recent studies have focused most intently on medicinal properties of Δ9-tetrahydrocannabinol (THC), the primary psychoactive chemical in cannabis, and cannabidiol (CBD), a non-psychoactive chemical that has recently been approved by the FDA under the trade name Epidiolex for the treatment of certain epileptic syndromes. These limitations on research have made it difficult to ascertain whether the combination of chemicals present in cannabis may have additional therapeutic utility or efficacy beyond that of its independent constituents.
Across the 33 states and the District of Columbia that permit medicinal use of cannabis, the conditions for which cannabis can be recommended vary considerably. The list of such conditions includes chronic pain, chemotherapy-induced nausea and vomiting, anorexia and weight loss associated with HIV, cancer, irritable bowel syndrome, epilepsy, spasticity, Tourette syndrome, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, Parkinson’s disease, dementia, traumatic brain injury, glaucoma, addiction, anxiety, depression, sleep disorders, posttraumatic stress disorder (PTSD), and schizophrenia and other psychoses. Needless to say, the strength of scientific support for therapeutic benefits of cannabis is not equivalent across these conditions. (The National Academies of Sciences, Engineering, and Medicine, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda, 2017.)
To determine the relative confidence with which cannabis can be considered therapeutic for these conditions, the National Academies of Sciences, Engineering, and Medicine (NASEM) conducted and published a comprehensive literature review and meta-analysis of the health effects of cannabis and cannabinoids in 2017. (Id. at p.19.) The analysis identified conclusive or near-conclusive evidence supporting that cannabis is effective in the treatment of chronic pain and chemotherapy-induced nausea and vomiting, and for improving spasticity symptoms resulting from multiple sclerosis. The analysis also found that there was some evidence to support cannabis as effective in treating fibromyalgia, increasing appetite and decreasing weight loss associated with HIV/AIDS, improving symptoms of Tourette syndrome, improving anxiety symptoms in patients with social anxiety disorders, and aiding sleep in patients with obstructive sleep apnea. In contrast, some studies suggests that cannabis is not effective for the treatment of dementia, glaucoma, or depression. (Id. at pp.26-27.)
There is considerably less clinical research exploring the pediatric use of medical cannabis, likely due to a combination of social stigma and procedural restrictions. The bulk of this research focuses on the use of cannabis for the abatement of seizures in treatment-refractory epilepsy and the treatment of nausea and vomiting induced by chemotherapy. Nonetheless, a meta-analysis of pediatric medicinal cannabis studies published in the journal Pediatrics demonstrated strong and consistent evidence for therapeutic utility in the treatment of pediatric epilepsy and pediatric chemotherapy-induced nausea and vomiting. (Wong & Wilens, Medical Cannabinoids in Children and Adolescents: A Systematic Review, Pediatrics, 2017; 140; DOI: 10.1542/peds.2017-1818, Oct. 23, 2017.) Studies also supported efficacy in the treatment of neuropathic pain, PTSD, spasticity, and Tourette syndrome in children and adolescents, but these studies were limited in size, number, and methodology. (Ibid.)
Some evidence suggests childhood and adolescent cannabis consumption can have negative developmental effects. The therapeutic benefits of pediatric medicinal cannabis must be balanced against the possibility of negative impacts on neurodevelopment as a result of childhood or adolescent cannabis exposure. Cannabinoids, the chemical constituents of cannabis, produce their effects by acting on a biological system, the endocannabinoid system, that also plays a role in development. In order to facilitate brain development during youth and adolescence, the brain temporarily amplifies this system, making the developing brain more sensitive to lasting neurological effects of cannabis. Several studies indicate that cannabis use during childhood or adolescence correlates with deficits in executive function, short-term memory, and emotional regulation. (NASEM, Health Effects of Cannabis, supra., pp.29-30.) Research has also demonstrated higher incidences of anxiety, depression, and psychosis in individuals who consumed cannabis during adolescence. (Ibid.) It should be noted, however, that these studies are retrospective and are not controlled, meaning the relationship between cannabis use and these deficits may not be causal. It is highly possible that prodromal anxiety, depression, or schizophrenia may increase the likelihood of consuming cannabis, either due to differences in reward mechanisms or as a means of self-medication. It is also possible that these putative effects of cannabis only manifest in individuals predisposed to psychiatric illness, but that they exacerbate the emergence of these disorders.
Still, when weighed against the severity of the conditions for which pediatric cannabis is most frequently recommended – epilepsy and chemotherapy-induced nausea and vomiting – the risk of these detrimental effects on development do not typically warrant abstaining from treatment, especially when other treatment options have been unsuccessful and therefore pediatric cannabis use under the supervision of a physician may be appropriate. In the case of epilepsy, abatement of seizures can dramatically reduce the risk of brain damage from extended episodes, so the effective use of medical cannabis may actually benefit neurodevelopment relative to the alternative.
This bill permits, but does not require, local school governing bodies to allow medicinal cannabis to be possessed and administered by caretakers of pupils on school premises. Conditions such as epilepsy that have been shown to respond favorably to treatment using medicinal cannabis often require regular administration throughout the day, as well as acute administration in the event of symptomatic episodes such as seizures. For instance, in a recent hearing before the Office of Administrative Hearings (OAH) of the State of California, the OAH held that an individualized education program for a student in the Rincon Valley Union Elementary School District suffering from Dravet Syndrome, a type of epilepsy that results in frequent seizures, could lawfully include prophylactic administration of CBD concentrate multiple times a day, as well as acute administration of THC oil in the event of a seizure. (Parent on Behalf of Student v. Rincon Valley Union Elementary School District (2018) OAH Case No. 2018050651.) The swift administration of THC oil upon seizure was deemed to be particularly critical, as seizures lasting longer than 15 minutes can result in brain damage. Still, it is unclear how this ruling affects policy relating to such administration statewide.
Because of this opacity, parents of children recommended for treatment with medicinal cannabis must, under current law, check their children out of school, transport them at least 1,000 feet from the school grounds, administer medication to the child, and then return the child to class. This practice seems highly disruptive to the student’s educational experience as it interrupts focus, singles out the student, and accumulates in a significant time for the student to be outside of the classroom. Additionally, this all but precludes the swift administration of acute cannabis-based treatment, for instance, in the event of a seizure. While administration by a caretaker on school grounds would still impose limitations on the latency to administration, circumventing the inconvenient transport of the student away from school grounds for administration would substantially expedite treatment.
This bill seeks to facilitate prompt and convenient administration of medicinal cannabis to school-age children by permitting local school governing bodies to adopt policies permitting medicinal cannabis administration by primary caretakers (i.e. parents, guardians, etc.) to pupils with valid recommendations on school grounds. The bill also provides a procedural framework upon which those policies must be based. The bill does not give parents statewide the right to administer the medicine to a child at school; rather, the bill would only authorize, but not require, local schools to implement such a policy, and in that case, would allow administration only under tightly prescribed restrictions: cannabis could not be smoked or vaped or administered in a way that would disrupt the educational environment or cause exposure to other students; after administering the cannabis, the parent must remove any remaining cannabis from the school site; the parent must sign in at the school before administering the cannabis; and the parent must provide a valid written medical recommendation for the student to be kept on file at the school. The bill in print would ensure the confidentiality of this information by restricting public access to these records, except as specified. Finally, the bill in print would allow a school that adopts such a policy to rescind the policy, for any reason, at a regular public meeting.
The bill in print provides more extensive confidentiality protections for records relating to medicinal use of cannabis on school premises than are provided for other medical records. Although California has been at the forefront of the medical cannabis movement, laws relating to medical cannabis suffer from a lack of clarity as to whether cannabis should be treated as a conventional medicine, or whether the federal prohibition and public perception of cannabis necessitates differential treatment. The conflict between the federal designation that cannabis lacks a safe and legitimate medical use and the acceptance by a majority of states to the contrary does indeed complicate the policy landscape. (See Atkins v. Virginia (2002), 536 U.S. 304, 312 (quoting Penry v. Lynaugh (1989) 492 U.S. 302, 331): “The ‘clearest and most reliable objective evidence of contemporary values is the legislation enacted by the country’s legislatures.’”) On one hand, federal prohibition of cannabis puts medicinal cannabis patients at risk of possible discrimination and federal prosecution in a manner unique from other medications, and it is also unclear whether federal protections relating to medical records apply to cannabis-related records. Additionally, medicinal applications for which cannabis can be recommended, though in most cases supported by strong scientific evidence, have often not met the burden of scientific proof typically necessary to qualify a drug for FDA approval. On the other hand, California has, based on the will of its voters, determined that cannabis can be properly used medicinally under state law, and ascribing medicinal legitimacy to a substance implies certain treatment and protection for its medical use. Non-uniform treatment of substances considered medicinal by the state risks the public perception that the state is preferentially categorizing or endorsing the medical use of certain drugs relative to others with similar safety and efficacy, and may discourage or encourage the use of specific drugs based on criteria other than the appropriateness for the treatment of the patient. It is thus necessary for California to take a more consistent approach to its treatment of medical cannabis.
The bill as currently in print provides for a degree of confidentiality in excess of typical medical records, prohibiting disclosure of these records for any reason absent a state or federal court order, and requiring the removal of these records from pupil records before releasing pupil records “for any reason under existing law.” Arguably, this could be justified by the aforementioned risks of discrimination and prosecution. However, this level of confidentiality also distinguishes the treatment of cannabis records maintained by the school from the treatment of similar records for other drugs, which may need to be considered in tandem for medical or other reasons. The increased confidentiality could thus be problematic in cases in which the sharing of medical records would be essential, or for other purposes of disclosure that have been identified as appropriate for medical records under existing law.
To provide consistency between the treatment of medical records relating to cannabis maintained by the school and the school’s other medical records, and to allow these records to be disclosed when appropriate, the author has agreed to amend the bill to treat the records collected relating to the administration of medicinal cannabis to a pupil like all other medical records for purposes of confidentiality and disclosure.
Lines 19-31 on page 3 of the bill be struck, and the following changes will be made to lines 16-18 of page 3 of the bill:
(c) (1) For purposes of confidentiality and disclosure, pupil Pupil records collected in accordance with a policy adopted pursuant to subdivision (a) for the purpose of administering medicinal cannabis to a pupil shall be treated as medical records, and shall be subject to all provisions governing the confidentiality and disclosure of medical records under state and federal law. are
The bill likely would not jeopardize federal funding, but has nonetheless properly anticipated and accounted for this risk. As mentioned previously, the legal question of federal preemption with respect to state cannabis laws is extremely complex and still has not been definitively settled. Nothing in federal law requires state enforcement of federal regulations, and there thus seem to be no preemption issues with the elimination of state laws, and consequently state enforcement, prohibiting medical cannabis consumption. However, whether or not an institution that plays an active role in permitting cannabis use on its premises could be prosecuted under federal law is less clear. This bill permits local school governing bodies to adopt policies in which school officials play an active role relating to allowance of cannabis consumption on school property, even if they are not directly administering it.
Under President Obama, the Justice Department, while still insisting that cannabis remained a controlled substance under federal law, announced that the federal government would not interfere with states that had legalized medical or recreational use of cannabis, so long as certain precautions were in place (e.g. protecting minors, preventing transport across state lines). In January of 2018, the U.S. Attorney General rescinded the Obama order and threatened more aggressive enforcement of federal law. Regardless, courts have held that language included in a rider to the 2018 and 2019 federal appropriations bills (See Consolidated Appropriations Act, Pub. L. No. 115-141, 115th Cong., 1st Sess., sec. 548, 132 Stat. 348, 444-445 (2018)) prohibits the Justice Department from “spending funds from relevant appropriations acts for the prosecution of individuals who engaged in conduct permitted by the State Medical Marijuana Laws and who fully complied with such laws.” (United States v. McIntosh (2016) 833 F.3d 1163, 1177.) Even if the federal government does not arrest medical or recreational users, however, it is possible that the federal government could withhold grants to schools that do not abide by federal law, most notably the Drug-Free Workplace Act.
Many California schools receive Title I funding for high poverty schools, as well as funding for school lunch and breakfast programs. Because cannabis is still a controlled substance under federal law, there has thus been some concern that actively and expressly permitting cannabis use – even as circumscribed by this bill – may jeopardize federal grant funding. The Drug-Free Workplace Act, enacted in 1988, requires any institutions receiving federal funds (including schools) to provide a drug-free workplace by taking the following steps: 1) publishing and distributing a policy statement prohibiting the unlawful manufacture, distribution, dispensation, possession or use of a controlled substance, 2) establishing a drug-free awareness program to inform employees to, inter alia, the dangers of drug abuse in the workplace and the drug-free workplace policy, 3) notifying employees that abiding by the terms of the policy statement and notifying the employer of criminal drug violations in the workplace are a condition of employment on a federal grant, 4) notifying the granting agency that the covered employee has been convicted of a criminal drug violation in the workplace, 5) imposing a penalty on any employee convicted of a reportable violation, and 6) making an ongoing, good faith effort to maintain a drug-free workplace by meeting these requirements.
The provisions of the Drug-Free Workplace Act apply specifically to drug-related activity in the workplace by employees of the institution, and is a system of notifications rather than of prohibitions. As such, the Act likely would not apply to passively permitting possession or administration of a controlled substance on the grounds of a school by a non-employee caretaker. This notion was supported by OAH decision in Rincon Valley, which provided the following:
[The] Drug-Free Workplace Act is wholly focused on preventing drug abuse by a grantee’s employees, a concern that does not arise here…because the nurse is not Rincon Valley’s employee. In any event, the prospect that the federal government would deprive Rincon Valley of federal funding for allowing Student on its campus with her life-sustaining seizure medication seems even more remote than the likelihood that it would charge Student, Mother, the nurse, or school officials with crimes. (Parent v. Rincon Valley (2018), supra, at p.21.)
Still, the fear that permitting the administration of medical cannabis on school grounds could jeopardize federal funding is not entirely unreasonable in light of the Justice Department’s proclaimed aggressive enforcement of federal criminalization of cannabis. Theoretically, the active permission, through record keeping, by employees of the school could be (in a legal reach) construed as aiding and abetting the possession, distribution, and use of a controlled substance on school property, which has been held to be criminal conduct under the Schoolyard Statute that provides enhanced penalties for drug crimes on school property (21 U.S.C. Section 860; United States v. Falu (1985) 776 F.2d 46.) The prospect that the current federal administration would attempt to use this power is by no means beyond the realm of possibility.
Nonetheless, the bill accounts for this possibility by expressly providing that a school governing body that adopted a policy pursuant to the bill’s provisions may rescind it at a regularly scheduled meeting of the governing board or body “for any reason, including, but not limited to, if the school district…is at risk of, or has lost, federal funding as a result of the policy.” Because regularly scheduled meetings must be noticed at least 72 hours in advance, however, and repercussions relating to the provision of federal funding may not accommodate such a schedule, the author has accepted an amendment to allow for the policy to be amended or rescinded at a special meeting of the governing body, compliant with provisions of the Brown Act, provided that exigent circumstances necessitate prompt action. The author has also agreed to amend the existing provision relating to regularly scheduled meetings by permitting amendment of a policy in addition to rescinding of the policy, in case fully rescinding the policy is not necessary. The proposed amendments add the words “amend or” after the word “may” on line 34 of page 3 of the bill in print, and add the following subsection, subject to non-substantive reconfiguration, prior to line 1 on page 4 of the bill in print:
(e) If exigent circumstances necessitate an immediate change to the policy adopted pursuant to subdivision (a), the governing board of a school district, a county board of education, or the governing body of a charter school that adopts a policy pursuant to subdivision (a) may amend or rescind the policy at a special meeting of the governing board or body, in full compliance with all applicable provisions of The Ralph M. Brown Act found in Chapter 9 of Part 1 of Division 2 of Title 5 of the Government Code (commencing with Section 54950).
The author has accepted a minor amendment to define cannabis and to include cannabis products under the provisions of the bill. Cannabis includes a variety of preparations, derivatives, and routes of administration. To clarify the inclusion of any such manifestation of cannabis as is medically recommended under the provisions of this bill, the author has agreed to include an existing, comprehensive definition of cannabis from the California Uniform Controlled Substances Act, that defines cannabis to mean “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of the plant’ and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin.” The definition also excludes industrial hemp, or the weight of any other ingredient combined with cannabis to prepare topical or oral administrations, food, drink, or other product. Furthermore, several statutes relating to the lawful consumption of cannabis for either medical or recreational use, refer to “cannabis or cannabis products,” including prohibitions on smoking or ingesting cannabis or cannabis products in a public place, smoking cannabis or cannabis products within 1,000 feet of a school, and smoking or ingesting cannabis or cannabis products in the passenger seat of a motor vehicle. (Health & Safety Code Section 11362.3.) While these particular sections do not apply specifically to medicinal use, it nonetheless seems appropriate to clarify that SB 223 applies to any preparation, including cannabis products. The author has thus agreed to insert the following language below line 3 of page 4 of the bill in print:
(f) For purposes of this section, “cannabis” shall include cannabis products.
(g) For purposes of this section, “cannabis” and “cannabis products” shall have the same meanings as in Chapter 1 of Division 10 of the Health and Safety Code.
(f) (h) For purposes of this section, “medicinal cannabis” excludes medicinal cannabis or cannabis products in a smokeable or vapeable form.
A bill identical to the bill in print, SB 1127, was vetoed by Governor Brown in 2018. The author of this bill also authored SB 1127, a bill identical to this bill as it is now in print, during the 2017-2018 legislative session. SB 1127 passed out of this Committee on a 7-3 party-line vote and passed off of the Assembly Floor following a motion to reconsider with 42 ayes, 29 noes, and 9 members not voting. The bill was vetoed by then-Governor Jerry Brown due to concerns about youth exposure to marijuana, both medically and otherwise. Governor Brown provided the following veto message:
I am returning Senate Bill 1127 without my signature.
This bill permits local schools to adopt policies regarding the use of medical marijuana by students on school grounds.
This bill is overly broad as it applies to all students instead of limited cases where a doctor recommends medical marijuana for a student in order to prevent or reduce the effects of a seizure. Generally, I remain concerned about the exposure of marijuana on youth and am dubious of its use for youth for all ailments. This bill goes too far -- further than some research has -- to allow use of medical marijuana for youth. I think we should pause before going much further down this path.
Arguments in Support: Supporters of the bill include several cannabis advocacy groups as well as the California School Boards Association, the San Mateo County Office of Education, and the Rincon Valley Union School District. The supporters contend that permitting the use of medical cannabis is essential to accommodating the educational needs of some students, including those with severe epilepsy which can result in debilitating seizures several times a day without treatment, and may be unresponsive to “conventional” treatments. They assert that many of these students require medical cannabis several times during the school day to abate these incidents, and that requiring the student to be picked up, transported 1,000 feet from school grounds, administered medicinal cannabis, and then returned to class is highly disruptive, takes significant time out of the student’s instruction, and deprives these students of a “typical” educational experience. They also point out that laws permitting medicinal cannabis possession and administration by a parent or other caregiver on school grounds exist in many other states that recognize the medicinal use of cannabis.
Americans for Safe Access, a national nonprofit dedicated to protecting the interests of medical cannabis patients, argue:
Washington, Colorado, Florida, Maine, New Jersey, Delaware, and Illinois have legislation in place that allows the administration of cannabis to minors on school grounds. New Mexico looks poised to join these states in the coming weeks. California has already taken preliminary steps to allow medicinal cannabis in schools, but the state needs a more comprehensive policy to encompass the needs of all minor patients throughout the state. In August 2018, an administrative law judge in Santa Rosa approved a kindergartener’s use of a cannabis-based drug for her seizure disorder, however, this is just one limited instance.
California Health Coalition Advocacy, a non-profit healthcare advocacy organization, adds:
Hundreds of kids all over California are being removed from school by their parents every day, driven 1,000 feet away, administered life-saving medicine, and then returned to class. It is unfair to make these kids miss class in order to be given medicine that gives them a higher quality of life, and sometimes even keeps them alive. It also makes their condition stand out at school, and it leads to confusion and emotional distress when they return to school after other students thought they were leaving for the day. SB 223 simply allows kids who are already receiving this medication to take it on campus in a way that does not disrupt the learning environment.
Arguments in Opposition: The California Police Chiefs Association, the sole known opponents of the bill, are primarily concerned that allowing cannabis near schoolsites in any capacity could be exploited to facilitate illicit use of cannabis by children.
The California Police Chiefs Association argues:
One of law enforcements top priorities is to prevent any youth under the age of 21 from accessing all types of cannabis products. While we understand some parents may choose to treat their student’s illnesses with cannabis, we are opposed to allowing parents or guardians administer the drug to their student while on school grounds. We are concerned this exemption would be exploited which could jeopardize the safety of the other students.
REGISTERED SUPPORT / OPPOSITION:
Support
Americans for Safe Access
California Cannabis Industry Association
California Health Coalition Advocacy
California School Boards Association
Consortium Management Group/Caliva
Rincon Valley Union School District
San Mateo County Office of Education
Southern California Coalition
Opposition
California Police Chiefs Association
Analysis Prepared by: Landon Klein / JUD. / (916) 319-2334
Date of Hearing: June 19, 2019
ASSEMBLY COMMITTEE ON EDUCATION
Patrick O'Donnell, Chair
SBPCA Bill Id:SB 223
Author:(Hill) – As Amended Ver:March 11, 2019
[Note: This bill is double referred to the Assembly Judiciary Committee and will be heard by that Committee as it relates to issues under its jurisdiction.]
SENATE VOTE: 29-4
SUBJECT: Pupil health: administration of medicinal cannabis: schoolsites
SUMMARY: Authorizes the governing board of a school district, a county board of education, and the governing body of a charter school maintaining kindergarten or any of grades 1 to 12 to adopt a policy that allows a parent or guardian to possess and administer non-smokeable and non-vapeable medicinal cannabis to an authorized pupil at a schoolsite. Specifically, this bill:
- Authorizes, notwithstanding other state law, the governing board of a school district, a county board of education, and the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt, at a regularly scheduled meeting of the governing board or body, a policy that allows a parent or guardian to possess and administer medicinal cannabis to a pupil at a schoolsite, if the pupil is a qualified patient pursuant to the Medical Marijuana Program.
- Requires the adopted policy to include, but not be limited to, all of the following elements:
- Prohibits a parent or guardian from administering the medicinal cannabis in a manner that creates a disruption to the educational environment or causes exposure to other pupils;
- Requires the parent or guardian to remove any remaining cannabis from the schoolsite after the parent or guardian administers the medicinal cannabis to the pupil;
- Requires the parent or guardian to sign in at the schoolsite before administering the medicinal cannabis;
- Requires the parent or guardian to provide, to an employee of the school, a valid written medical recommendation for medicinal cannabis for the pupil, and requires that the school keep the recommendation on file at the school;
- Specifies that pupil records collected in accordance with a policy adopted pursuant to (1) above are confidential and to be used only for the purpose of administrating medicinal cannabis to the pupil, and prohibits the disclosure of these pupil records for any reason, except as required by a state or federal court order; and
- Specifies that the right to access particular pupil records for legitimate education interests do not apply to pupil records collected for the purpose of administrating medicinal cannabis, and that such records must be removed from the pupil’s records before any of the pupil’s records are released for any reason under existing law.
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school to rescind the policy at a regularly scheduled meeting of the governing board or body for any reason, including, but not limited to, if the school district, county office of education, or charter school is at risk of, or has lost, federal funding as a result of the policy.
- States that none of the bill’s provisions require the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Excludes medicinal cannabis in a smokeable or vapeable form from the provisions of this bill.
- Expresses findings and declarations that, in order to protect the privacy of pupils, and parents and guardians of pupils who are administered medicinal cannabis, it is necessary that pupil records collected for the purpose of administrating medicinal cannabis be confidential.
EXISTING LAW:
Existing federal law:
- Classifies “marihuana” as a Schedule I drug. Under federal law, all Schedule I drugs have the following properties:
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision. (Title 21, United States Code (USC), 812(b)(1))
- Defines “marihuana” as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin. Such term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination.” (21 USC 802(16))
- Requires recipients of federal grants to comply with the Drug-Free Workplace Act, which requires institutions receiving any federal grant to prohibit the manufacture, use and distribution of controlled substances in the workplace. Makes failure to comply with the Drug-Free Workplace Act grounds for suspension or termination of the federal grant. (21 USC 8103)
Existing State law:
- Provides, through Proposition 215 of 1996, the Compassionate Use Act, that individuals have the right to obtain and use marijuana for medical purposes where medical use has been deemed appropriate and recommended by a physician because the person’s health would benefit from the use of marijuana in treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief. (Health & Safety Code (HSC) 11362.5)
- Defines terms under the Medical Marijuana Program, including “primary caregiver” as the individiual designated by a qualified patient who has consistently assumed responsibility for the housing, health, or safety of that patient; and a “qualified patient” as a person who is entitled to the protections in (1) above, but who does not have an identification card issued. (HSC 11362.7)
- Removes the criminal penalties for cultivation and possession of marijuana by qualified patients who are persons with a physician’s written or oral recommendation or approval to use marijuana for medical use, or by their primary caregivers, and protects physicians from punishment for recommending marijuana to a patient for medical purposes. (HSC 11362.5)
- Specifies that participation in the Medical Marijuana Program does not authorize a qualified patient to engage in the smoking of medical marijuana under any of the following circumstances:
- In any place where smoking is prohibited by law;
- In or within 1,000 feet of the grounds of a school, recreation center, or youth center, unless the medical use occurs within a residence;
- On a school bus;
- While in a motor vehicle that is being operated; and
- While operating a boat. (HSC 11362.79)
- States that, except as authorized by law, a person 18 years of age or older who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs is guilty of a misdemeanor. (HSC 11357)
FISCAL EFFECT: This bill has been keyed fiscal by the Office of Legislative Counsel.
COMMENTS:
Need for the bill. According to the author, “SB 223 will help students with severe medical disabilities attend school. The only medication that works for some of these students is medical cannabis. This bill will allow a parent or guardian to come on campus to administer medical cannabis to them in non-smoking and non-vaping forms.”
Potential for medical benefits from medicinal cannabis. The federal government classifies cannabis as a Schedule I drug, as it does not recognize any currently accepted medical use in treatment in the United States. However, at least one study indicates medicinal cannabis may be particularly effective in treating Lennox-Gastaut syndrome, a rare, severe form of epileptic encephalopathy. The federal government appears to be moving towards approving the use of marijuana derived prescription drugs for the treatment of certain health issues, as specified in a recent bulletin put out by the National Center for Complementary and Integrative Health, one of the National Institutes of Health:
On June 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains cannabidiol, a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.
In April, the Peripheral and Central Nervous System Drugs Advisory Committee of the FDA unanimously recommended that the agency approve the new medicine after concluding that the results from three adequate and well-controlled trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome provided substantial evidence of the effectiveness of cannabidiol for the treatment of seizures associated with these syndromes. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with a placebo.
Other states have recently approved similar measures. In 1996, California became the first state to approve medical marijuana. According to the National Conference of State Legislatures, since then, an additional 29 states, the District of Colombia, Guam, and Puerto Rico have followed suit and now allow for comprehensive public medical marijuana programs. An additional 17 states allow the use of “low THC, high cannabidiol (CBD)” for medical reasons.
More recently, five of the 29 states with comprehensive medical marijuana programs (Washington, Colorado, Florida, Maine, and New Jersey) have enacted laws authorizing students to use medical cannabis on school campuses. According to the Education Commission of the States, both New Jersey and Colorado require that:
- Students using medicinal marijuana products have a valid medical recommendation;
- Only non-smokable marijuana products may be administered on school grounds;
- Only parents, legal guardians or primary caregivers administer the substance; and
- Students cannot be punished for marijuana use on school grounds.
Maine’s statute differs from those states because policymakers worked from the state’s existing medical marijuana framework and simply expanded the locations in which medical marijuana use is permissible. Alternatively, Washington has taken a slightly different path and instead specifies that schools are not required to permit on-site use of medical marijuana, but are permitted to allow it if they choose. Conversely, Florida requires each district school board is required to adopt a policy and procedure.
This bill follows Washington’s opt-in approach for schools, but, like Colorado and New Jersey, prescribes some uniform conditions such as only authorizing non-smokeable, non-vapeable products, authorizing only parents and legal guardians to administer the medicinal cannabis to the pupil at school, requiring the parent to furnish a written medical recommendation to the school and to sign in upon entering the school, and provides for the privacy of the pupil records.
Possible federal funding risk. In January 2018, U.S. Attorney General Sessions issued a Marijuana Enforcement Memorandum that allows federal prosecutors to decide how to prioritize enforcement of federal marijuana laws. Specifically, the memorandum directs U.S. Attorneys to “weigh all relevant considerations, including federal law enforcement priorities set by the Attorney General, the seriousness of the crime, the deterrent effect of criminal prosecution, and the cumulative impact of particular crimes on the community.”
California receives federal funding for schools primarily in two ways: Title I funding for high poverty schools and funding for the National School Lunch Program and School Breakfast Program. Federal grants are subject to federal regulations implementing drug-free workplace requirements. Noncompliance with those requirements could result in the loss of federal funding, as grantees and sub-grantees must make a “good faith effort” to maintain a drug-free workplace as a condition of the grant award. A drug-free workplace includes any location where the performance of work is done in connection with a specific award, which could include school buildings in Title I schools and schools that participate in federal school meal programs.
Federal agencies have discretion in determining whether a grantee or sub-grantee is in violation of the drug-free workplace requirements, and have a range of options to compel compliance. When the Colorado Legislative Council staff analyzed this issue for their state, it assumed that withholding federal funds is the last and most extreme action the federal government can take, and that any conflict between state laws and federal rules can be addressed without forfeit of federal grants and other distributions. Moreover, this bill specifically allows for any local educational agency that has adopted a policy to allow parents or guardians to administer appropriate medicinal cannabis to rescind that policy for any reason, including the risk of losing funding.
Arguments in support. The California School Boards Association states, “The Individuals with Disabilities Education Act (IDEA) requires schools to provide accommodations for all children to attend school. Since it’s against the law for kids to take medical cannabis on campus at public schools, some school districts must pay for these students to go to private school, where it can be administered on campus. As the uses of medical cannabis have expanded, doctors are recommending its use to address a variety of issues. Some students need medical cannabis to be able to attend school and have normal childhood experiences. Currently, these students must be picked up by their parents and taken off campus in order to take their dosage. This is disruptive to their learning. Every child is entitled to an uninterrupted education. This bill allows the medical needs of students to be addressed to ensure they receive an appropriate education.”
Arguments in opposition. The California Police Chiefs Association states, “One of law enforcements top priorities is to prevent any youth under the age of 21 from accessing all types of cannabis products. While we understand some parents may choose to treat their student’s illnesses with cannabis, we are opposed to allowing parents or guardians administer the drug to their student while on school grounds. We are concerned this exemption would be exploited which could jeopardize the safety of the other students. For these reasons, we must oppose this measure.”
Related legislation. SB 1127 (Hill) of the 2017-18 Session was virtually identical to this bill. The bill was vetoed by the Governor, with the following message:
This bill permits local schools to adopt policies regarding the use of medical marijuana by students on school grounds. This bill is overly broad as it applies to all students instead of limited cases where a doctor recommends medical marijuana for a student in order to prevent or reduce the effects of a seizure. Generally, I remain concerned about the exposure of marijuana on youth and am dubious of its use for youth for all ailments. This bill goes too far -- further than some research has -- to allow use of medical marijuana for youth. I think we should pause before going much further down this path.
SB 1266 (Huff), Chapter 321, Statutes of 2014, requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered to administer the medication, as specified. Authorizes school nurses or trained personnel to use the epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
Proposition 64, The Compassionate Use Act, November 5, 1996, legalized the use of medicinal marijuana.
REGISTERED SUPPORT / OPPOSITION:
Support
Americans For Safe Access
California Cannabis Industry Association
California Health Coalition Advocacy
California School Boards Association
Consortium Management Group
Rincon Valley Union School District
San Mateo County Office Of Education
Southern California Coalition
United Cannabis Business Association
Opposition
California Police Chiefs Association
Analysis Prepared by: Debbie Look / ED. / (916) 319-2087
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SB 223 |
THIRD READING
Bill No: SB 223
Amended: 3/11/19
SENATE EDUCATION COMMITTEE: 6-0, 3/20/19
AYES: Leyva, Wilk, Durazo, Glazer, McGuire, Pan
NO VOTE RECORDED: Chang
SENATE JUDICIARY COMMITTEE: 7-1, 3/26/19
AYES: Jackson, Allen, Caballero, Monning, Stern, Umberg, Wieckowski
NOES: Borgeas
SUBJECT: Pupil health: administration of medicinal cannabis: schoolsites
DIGEST:
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite.
Existing federal law:
- Classifies “marihuana” as a Schedule I drug. Under federal law, all Schedule I drugs have the following properties:
- “The drug or other substance has a high potential for abuse;”
- “The drug or other substance has no currently accepted medical use in treatment in the United States;” and
- “There is a lack of accepted safety for use of the drug or other substance under medical supervision.” (Title 21, United States Code, § 812(b)(1))
- Defines “marihuana” as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin. Such term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination.” (21 USC § 802(16))
- Requires recipients of federal grants to comply with the Drug-Free Workplace Act, which requires institutions receiving any federal grant to prohibit the manufacture, use and distribution of controlled substances in the workplace. Failure to comply with the Drug-Free Workplace Act is grounds for suspension or termination of the federal grant. (21 USC §§ 8103))
Existing state law:
- Provides, through Proposition 215 of 1996, the Compassionate Use Act, that individuals have the right to obtain and use marijuana for medical purposes where medical use has been deemed appropriate and recommended by a physician because the person’s health would benefit from the use of marijuana in treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief. (Health & Safety Code (HSC) § 11362.5(b)(1)(A))
- Removes the criminal penalties for cultivation and possession of marijuana by qualified patients, who are persons with a physician’s written or oral recommendation or approval to use marijuana for medical use, or by their primary caregivers, and protects physicians from punishment for recommending marijuana to a patient for medical purposes. (HSC § 11362.5(d) and (e))
- Specifies that participation in the Medical Marijuana Program shall not authorize a qualified patient to engage in the smoking of medical marijuana under any of the following circumstances:
- In any place where smoking is prohibited by law;
- In or within 1,000 feet of the grounds of a school, recreation center, or youth center, unless the medical use occurs within a residence;
- On a school bus;
- While in a motor vehicle that is being operated; or
- While operating a boat. (HSC § 11362.79)
- Specifies that, except as authorized by law, a person 18 years of age or older who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs is guilty of a misdemeanor and shall be punished as follows:
- A fine of not more than two hundred fifty dollars ($250), upon a finding that a first offense has been committed.
- A fine of not more than five hundred dollars ($500), or by imprisonment in a county jail for a period of not more than 10 days, or both, upon a finding that a second or subsequent offense has been committed. (HSC § 11357(c))
- Specifies that a person 18 years of age or over who:
- Hires, employs, or uses a minor in unlawfully transporting, carrying, selling, giving away, preparing for sale, or peddling any cannabis, who unlawfully sells, or offers to sell, any cannabis to a minor, or who furnishes, administers, or gives, or offers to furnish, administer, or give any cannabis to a minor under 14 years of age, or who induces a minor to use cannabis in violation of law shall be punished by imprisonment in the state prison for a period of three, five, or seven years.
- Furnishes, administers, or gives, or offers to furnish, administer, or give, any cannabis to a minor 14 years of age or older in violation of law shall be punished by imprisonment in the state prison for a period of three, four, or five years.
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite. Specifically, this bill:
- Authorizes, notwithstanding state law identified in (4) and (5) above, the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt, at a regularly scheduled meeting of the governing board or body, a policy that allows a parent or guardian of a pupil to possess and administer to the pupil who is a qualified patient pursuant to Medicinal Marijuana Program.
- Requires the adopted policy to include at least all of the following elements:
- A prohibition against a parent or guardian from administering medicinal cannabis in a manner that creates a disruption to the educational environment or causes exposure to other pupils.
- A requirement for the parent or guardian to remove any remaining cannabis from the schoolsite after the parent or guardian administers the medicinal cannabis.
- A requirement for the parent or guardian to sign in at the schoolsite before administering the medicinal cannabis.
- A requirement that before administering the medicinal cannabis, the parent or guardian must provide to an employee of the school a valid written medical recommendation for medicinal cannabis for the pupil to be kept on file at the school.
- Provides the following with regards to the pupil records collected in accordance with the adopted policy for the administration of medicinal cannabis to a pupil:
a) Specifies that the records are confidential.
- Requires the records be used only for the purpose of administration of medicinal cannabis to the pupil.
- Prohibits the records from being open to the public for inspection or disclosed for any reason, except as required by a state or federal court order.
- States legislative findings and declarations that the provisions in (a) to (c) impose a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution, and that pursuant to that constitutional provision, that the Legislature finds, to demonstrate the interest protected by this limitation and the need for protecting that interest, that in order to protect the privacy of pupils, and parents and guardians of pupils, who are administered medicinal cannabis, it is necessary that pupil records collected for the purpose of administration of medicinal cannabis be confidential.
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school to rescind the policy at a regularly scheduled meeting of the governing board or body for any reason, including, but not limited to, if the school district, county office of education, or charter school is at risk of, or has lost, federal funding as a result of the policy.
- Specifies that none of the bill’s provisions require the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Prohibits medicinal cannabis in a smokeable or vapeable form for purposes of the bill.
Comments
- Need for the bill. According to the author, “Some students need medical cannabis to be able to attend school and have normal childhood experiences. Currently, these students must be picked up by their parents and taken off campus in order to take their medicine. This is disruptive to their learning. Every child is entitled to an uninterrupted education. The Compassionate Use Act of 1996 (Proposition 215) allows minors to use medical cannabis with the consent of their parents and a recommendation from a doctor… Many of these minors need to take a dose of medical cannabis at regular intervals, which often includes during school hours. Current law does not allow any form of cannabis on school grounds. Existing law allows schools to legally administer any pharmaceutical drug, including opioids, that a child has been prescribed. But there are medical conditions pharmaceuticals can’t fix, and they often have debilitating side effects. Medical cannabis helps fill some of these gaps, and lessen these challenging side effects.”
- Potential for medical benefits from medicinal cannabis. On July 25, 2018, the United States Food and Drug Administration (FDA) approved Epidiolex, the drug used in the trial published in The Lancet, as an oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. According to the FDA, “it is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA-approval of a drug for the treatment of patients with Dravet syndrome.” In its announcement of the approval, the FDA stated that “Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo.”
- Other states have recently approved similar measures. In 1996, California became the first state to approve medical marijuana. According to the National Conference of State Legislatures, since then, an additional 28 states, the District of Colombia, Guam, and Puerto Rico have followed suit and now allow for comprehensive public medical marijuana programs. An additional 17 states allow the use of “low THC, high cannabidiol (CBD)” for medical reasons or as a legal defense.
More recently, five of the 29 states with comprehensive medical marijuana programs: Washington, Colorado, Florida, Maine, and New Jersey have enacted laws authorizing students to use medical cannabis on school campuses. According to the Education Commission of the States, “While it is too soon to identify specific trends in policies, both New Jersey and Colorado require that:
- Students using medicinal marijuana products have a valid medical recommendation.
- Only non-smokable marijuana products may be administered on school grounds.
- Only parents, legal guardians or primary caregivers administer the substance.
d) Students cannot be punished for marijuana use on school grounds.”
Maine’s law differs from those states because policymakers worked from the state’s existing medical marijuana framework and simply expanded the locations in which medical marijuana use is permissible. Alternatively, Washington has taken a slightly different path and instead specifies that schools are not required to permit on-site use of medical marijuana, but are permitted to allow it if they choose. Conversely, Florida requires each district school board to adopt a policy and procedure. Additionally, New Mexico’s legislature has introduced legislation this session, Senate Bill 204, to authorize students to received medicinal marijuana on school campuses. As of March 13, 2019, the bill has passed both houses of the New Mexico legislature and is pending before the Governor.
Here, this bill strikes an appropriate balance between these different approaches, mimicking Washington’s opt-in approach but prescribing some uniform conditions like Colorado and New Jersey, such as only authorizing non-smokeable, non-vapeable products and only authorizing parents and legal guardians.
- Federal funding risk? In 2018-19, California received approximately $8.2 billion in federal funding for schools. Federal grants are subject to federal regulations implementing drug-free workplace requirements. Noncompliance with those requirements could result in the loss of federal funding, as grantees and sub-grantees must make a “good faith effort” to maintain a drug-free workplace as a condition of the grant award. A drug-free workplace includes any location where the performance of work is done in connection with a specific award, which could include school buildings in Title I schools and schools that participate in federal programs such as National School Lunch Program or School Breakfast Program. Importantly, federal agencies have discretion in determining whether a grantee or sub-grantee is in violation of the drug-free workplace requirements, and have a range of options to compel compliance. When the Colorado Legislative Council Staff analyzed this issue for their state, it assumed “that withholding federal funds is the last and most extreme action the federal government can take, and that any conflict between state laws and federal rules can be addressed without forfeit of federal grants and other distributions.” Moreover, this bill specifically allows for any local educational agency that has adopted a policy to allow parents or guardians to administer appropriate medicinal cannabis to rescind that policy for any reason, including the risk of losing funding.
Related/Prior Legislation
SB 1127 (Hill, 2018) was identical to this bill and was vetoed by Governor Brown, who stated:
“This bill is overly broad as it applies to all students instead of limited cases where a doctor recommends medical marijuana for a student in order to prevent or reduce the effects of a seizure. Generally, I remain concerned about the exposure of marijuana on youth and am dubious of its use for youth for all ailments. This bill goes too far -- further than some research has -- to allow use of medical marijuana for youth. I think we should pause before going much further down this path.”
SB 1266 (Huff, Chapter 321, Statutes of 2014) required school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered, as specified. Authorized school nurses or trained personnel to use the epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
SB 1051 (Huff, 2010) would have authorized a school district, until January 1, 2016, to provide nonlicensed school employees with voluntary training for the provision of emergency medical assistance to a pupil suffering from an epileptic seizure, in the absence of licensed personnel. SB 1051 died in the Senate Appropriations Committee.
AB 1430 (Swanson, 2009) would have provided that only a credentialed school nurse may administer medication to pupils, but did specifically allow non-medical school personnel to administer epinephrine via auto-injector and insulin in cases of an emergency. AB 1430 was never heard in committee.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
Americans for Safe Access
California Cannabis Industry Association
California Health Coalition Advocacy
California NORML
California School Boards Association
CannaKids
Rincon Valley Union School District
Southern California Coalition
United Cannabis Business Association
Numerous individuals
OPPOSITION: (Verified 3/27/19)
None received
Prepared by: Brandon Darnell / ED. /
3/27/19 13:15:04
Senator Hannah-Beth Jackson, Chair
2019-2020 Regular Session
Bill No: SB 223 (Author:Hill)
Version: March 11, 2019
Hearing Date: March 26, 2019
Fiscal: No
Urgency: No
Consultant: MEC
SUBJECT
Pupil health: administration of medicinal cannabis: schoolsites
DIGEST
This bill codifies Jojo’s Act to allow the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, to adopt a policy that would allow a parent or guardian to possess and administer medical cannabis to their child at a schoolsite, as specified.
EXECUTIVE SUMMARY
Cannabis, also known as Marijuana, is a plant that has been used for medicinal purposes for thousands of years.[1] In 1996, California voters passed Proposition 215, the Compassionate Use Act, “to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes.” Although California and other states approved the use of medicinal marijuana, and subsequently the recreational use of marijuana, the federal government continues to treat marijuana as a dangerous drug. Physicians in California can recommend the use of medicinal marijuana by an adult or child. However, children cannot be administered their medicinal marijuana at school because state law prohibits cannabis on school grounds. As a result, some children who would like to attend public schools are not able to because they cannot take their medicine while at school. Other parents retrieve their children from school grounds and take them off campus to administer their medicinal cannabis and subsequently return the children to school. This bill allows parents or guardians to administer medicinal marijuana to their children on school grounds, as specified, if the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, adopt a policy that allows it.
This bill is author sponsored and supported by the California School Boards Association as well as educators, parents, and allies who highlight how medicinal marijuana has helped children with their medical conditions. There is no known opposition to this measure. This bill passed out of the Senate Committee on Education on a 6 to 0 vote on March 20, 2019. This exact bill was sent to Governor Jerry Brown and vetoed in 2018.
PROPOSED CHANGES TO THE LAW
Existing state law:
- Proposition 215 of 1996, the Compassionate Use Act, confers on a person the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the person’s health would benefit from the use of marijuana in treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief. (Health & Saf. Code § 11362.5(b)(1).)
- Removes the criminal penalties for cultivation and possession of marijuana by qualified patients, who are persons with a physician’s written or oral recommendation or approval to use marijuana for medical use, or by their primary caregivers, and protects physicians from punishment for recommending marijuana to a patient for medical purposes. (Health & Saf. Code § 11362.5(b), (c) and (d).)
- Provides that the Medical Marijuana Program does not authorize a qualified patient or person with an identification card to engage in the smoking of medicinal cannabis under any of the following circumstances: in a place where smoking is prohibited by law; in or within 1,000 feet of the grounds of a school, recreation center, or youth center, unless the medicinal use occurs within a residence; on a school bus; while in a motor vehicle that is being operated; or while operating a boat. (Health & Saf. Code § 11362.79)
- Provides that, except as authorized by law, a person 18 years of age or older who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs is guilty of a misdemeanor and shall be punished as follows: a fine of not more than two hundred fifty dollars ($250), upon a finding that a first offense has been committed; a fine of not more than five hundred dollars ($500), or by imprisonment in a county jail for a period of not more than 10 days, or both, upon a finding that a second or subsequent offense has been committed. (Health & Saf. Code § 11357(c).)
- Provides that, except as authorized by law, a person under 18 years of age who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs, is guilty of an infraction and shall be required to: upon a finding that a first offense has been committed, complete eight hours of drug education or counseling and up to 40 hours of community service over a period not to exceed 90 days; upon a finding that a second or subsequent offense has been committed, complete 10 hours of drug education or counseling and up to 60 hours of community service over a period not to exceed 120 days. (Health & Saf. Code § 11357(d).)
- Provides that a person 18 years of age or over who furnishes, administers, or gives, or offers to furnish, administer, or give any cannabis to a minor under 14 years of age, or who induces a minor to use cannabis in violation of law shall be punished by imprisonment in the state prison for a period of three, five, or seven years. (Health & Saf. Code § 11361(a).)
- Provides that a person 18 years of age or over who furnishes, administers, or gives, or offers to furnish, administer, or give, any cannabis to a minor 14 years of age or older in violation of law shall be punished by imprisonment in the state prison for a period of three, four, or five years. (Health & Saf. Code § 11361(b).)
Existing federal law classifies marijuana as a Schedule I drug. (Title 21 U.S.C. § 812(b)(1).)
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite. Specifically, this bill:
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt, at a regularly scheduled meeting of the governing board or body, a policy that allows a parent or guardian of a pupil to possess and administer to the pupil who is a qualified patient pursuant to Medicinal Marijuana Program.
- Requires the adopted policy to include at least all of the following elements:
- A prohibition against a parent or guardian from administering the medicinal cannabis in a manner that creates a disruption to the educational environment or causes exposure to other pupils.
- A requirement for the parent or guardian to remove any remaining cannabis from the schoolsite after the parent or guardian administers the medicinal cannabis.
- A requirement for the parent or guardian sign in at the schoolsite before administering the medicinal cannabis.
- A requirement that before administering the medicinal cannabis, the parent or guardian must provide to an employee of the school a valid written medical recommendation for medicinal cannabis for the pupil to be kept on file at the school.
- Provides the following with regards to the pupil records collected in accordance with the adopted policy for the administration of medicinal cannabis to a pupil:
- Specifies that the records are confidential.
- Requires the records be used only for the purpose of administration of medicinal cannabis to the pupil.
- Prohibits the records from being open to the public for inspection or disclosed for any reason, except as required by a state or federal court order.
- States Legislative findings and declarations that the provisions in (a) to (c) impose a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution, and that pursuant to that constitutional provision, that the Legislature finds, to demonstrate the interest protected by this limitation and the need for protecting that interest, that in order to protect the privacy of pupils, and parents and guardians of pupils, who are administered medicinal cannabis, it is necessary that pupil records collected for the purpose of administration of medicinal cannabis be confidential.
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school to rescind the policy at a regularly scheduled meeting of the governing board or body for any reason, including, but not limited to, if the school district, county office of education, or charter school is at risk of, or has lost, federal funding as a result of the policy.
- Specifies that none of the bill’s provisions require the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Excludes specifically, for purposes of the bill, medicinal cannabis in a smokeable or vapeable form.
COMMENTS
1. Intent of the bill
According to the author:
SB 223 (Jojo’s Act) will help students with severe medical disabilities attend school. The only medication that works for some of these students is medical cannabis. This bill will allow a parent or guardian to come on campus to administer medical cannabis to them in non-smoking and non-vaping forms.
Many of these students need to take a dose of medical cannabis at regular intervals, which often includes during school hours. Current law does not allow any form of cannabis on school grounds. These students must be picked up by their parents, signed out, and taken off campus in order to take their medicine. This is very disruptive to their learning.
SB 223 (Jojo’s Act) will allow the governing board of a K-12 school district, county board of education, or a charter school to choose whether to adopt this policy. It is not a state mandate. Districts and counties that opt-in can opt-out for any reason, including if federal funding is put at risk as a result of this policy.
SB 223 (Jojo’s Act) requires the student to be a qualified medical cannabis patient with a doctor’s recommendation. Typically the medicine is administered as oil, capsules, tinctures, liquids, or topical creams.
The bill also requires that a parent must:
- Give the school a copy of their child’s medical cannabis recommendation to keep on file
- Sign in when they come on campus to administer the medicine
- Not disrupt the educational environment
- Take all cannabis from school grounds after administration.
Existing law allows schools to legally administer any pharmaceutical drug, including opioids, that a child has been prescribed. But there are medical conditions pharmaceuticals can’t fix, and they often have debilitating side effects. Medical cannabis helps fill some of these gaps, and lessen these challenging side effects. Parents across the nation have had success treating their children with medical cannabis when no pharmaceutical would work.
Washington, Colorado, Florida, Maine, and New Jersey have all passed legislation allowing students to use medical cannabis on school campuses.
In support, the Rincon Valley Union School District explains:
Parents and physicians have found that many debilitating diseases can be treated using medical cannabis. Not allowing its administration on school campuses, forces parents to choose between the health of their child and their child’s comprehensive public education.
The Individuals with Disabilities Education Act (IDEA) requires that school districts offer a free and appropriate public education. Since it is against the law for schools to administer medical cannabis on a school campus, school districts are caught between offering the required free and appropriate public education or complying with tobacco free schools/cannabis free campus regulations. Schools and districts are then forced to contract with and fund placement for students at private schools.
2. Federal law is still in tension with California law regarding medicinal cannabis
California voters enacted the Compassionate Use Act in 1996 in order to permit the use of marijuana for medical purposes by persons deemed qualified by their physicians. In 1996, marijuana was an illegal drug under federal and state law, and its use, possession, distribution, cultivation, or sale carried significant penalties. Twenty years later, California voters approved the recreational use of marijuana for adults through Proposition 64, the Adult Use of Marijuana Act. However, under federal law, marijuana is classified as a Schedule I drug. Under federal law, Schedule I drugs: have a high potential for abuse; have no currently accepted medical use in treatment in the United States; and lack accepted safety for use of the drug or other substance under medical supervision. Possession of marijuana, even by medical users, continues to be a federal crime under the Controlled Substances Act. Under the Controlled Substances Act, it is unlawful for any person knowingly or intentionally…to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense a controlled substance. (21 U.S.C. § 841(a).)
The federal government seems to be moving towards approving the use of marijuana derived prescription drugs for the treatment of certain health issues, as specified in a recent bulletin put out by the National Center for Complementary and Integrative Health, one of the National Institutes of Health:
On June 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains cannabidiol, a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.
In April, the Peripheral and Central Nervous System Drugs Advisory Committee of the FDA unanimously recommended that the agency approve the new medicine after concluding that the results from three adequate and well-controlled trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome provided substantial evidence of the effectiveness of cannabidiol for the treatment of seizures associated with these syndromes. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo. The most common side effects that occurred in Epidiolex-treated patients in the clinical trials were: sleepiness, sedation and lethargy; elevated liver enzymes; decreased appetite; diarrhea; rash; fatigue, malaise and weakness; insomnia, sleep disorder and poor-quality sleep; and infections.
In general, the risks associated with cannabidiol treatment appear acceptable, particularly given the findings of clinical efficacy in Lennox-Gastaut syndrome and Dravet syndrome, which are serious, debilitating, and life-threatening disorders. Although there is risk of liver injury with cannabidiol, the committee concluded that the observed risk could be appropriately managed with inclusion of relevant language in labeling, education of prescribers regarding the risk of transaminase elevation and need for monitoring of liver enzyme levels, and further characterization of the risk in the post-market setting.
(National Center for Complementary and Integrative Health, one of the National Institutes of Health: Component of Marijuana Reduces Seizures in Some Children With Epilepsy <http://nccih.nih.gov/news/cannabidiol> [as of March 20, 2019].)
This Committee has received several letters from parents, health professionals, and others urging the committee to pass this legislation because they, their friends, or family members have benefitted from medicinal cannabis. One such letter detailed how a child, who needs CBD oil to ease seizures, “must be removed from class and walked at least 1000 ft. off campus, receive his medication, then taken back and be reintroduced into the class.”
2. Governor’s Veto
Governor Jerry Brown vetoed SB 1127 (Hill, 2018), a bill identical to the bill currently before this committee. The Governor wrote the following:
I am returning Senate Bill 1127 without my signature.
This bill permits local schools to adopt policies regarding the use of medical marijuana by students on school grounds.
This bill is overly broad as it applies to all students instead of limited cases where a doctor recommends medical marijuana for a student in order to prevent or reduce the effects of a seizure. Generally, I remain concerned about the exposure of marijuana on youth and am dubious of its use for youth for all ailments. This bill goes too far -- further than some research has -- to allow use of medical marijuana for youth. I think we should pause before going much further down this path.
SUPPORT
Americans for Safe Access
California Cannabis Industry Association
California Health Coalition Advocacy
California NORML
California School Boards Association
CannaKids
Rincon Valley Union School District
Southern California Coalition
20 individuals
OPPOSITION
None known
RELATED LEGISLATION
Pending: None known
Prior:
SB 1127 (Hill, 2018) Identical to the bill currently before this committee. The Governor vetoed the bill.
Proposition 215 (The Adult Use of Marijuana Act, November 8, 2016), legalized the recreational use of marijuana.
Proposition 64 (The Compassionate Use Act, November 5, 1996), legalized the use of medicinal marijuana.
PRIOR VOTES:
Prior Vote: Senate Education Committee, 6-0
**************
“People have used marijuana, also called cannabis, for a variety of health conditions for at least 3,000 years.” National Center for Complementary and Integrative Health, one of the National Institutes of Health, Medical Marijuana <http://nccih.nih.gov/health/marijuana> [as of March 15, 2019] ↑
SENATE COMMITTEE ON EDUCATION
Senator Connie Leyva, Chair
2019 - 2020 Regular
Bill No: SB 223 Hearing Date: March 20, 2019
Author: | Hill | ||
Version: | March 11, 2019 | ||
Urgency: | No | Fiscal: | No |
Consultant: | Brandon Darnell | ||
Subject: Pupil health: administration of medicinal cannabis: schoolsites.
SUMMARY
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite.
BACKGROUND
Existing federal law:
- Classifies “marihuana” as a Schedule I drug. Under federal law, all Schedule I drugs have the following properties:
- “The drug or other substance has a high potential for abuse;”
- “The drug or other substance has no currently accepted medical use in treatment in the United States;” and
- “There is a lack of accepted safety for use of the drug or other substance under medical supervision.” (Title 21, United States Code, § 812(b)(1))
- Defines “marihuana” as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin. Such term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination.” (21 USC § 802(16))
- Requires recipients of federal grants to comply with the Drug-Free Workplace Act, which requires institutions receiving any federal grant to prohibit the manufacture, use and distribution of controlled substances in the workplace. Failure to comply with the Drug-Free Workplace Act is grounds for suspension or termination of the federal grant. (21 USC §§ 8103))
Existing state law:
- Provides, through Proposition 215 of 1996, the Compassionate Use Act, that individuals have the right to obtain and use marijuana for medical purposes where medical use has been deemed appropriate and recommended by a physician because the person’s health would benefit from the use of marijuana in treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief. (Health & Safety Code § 11362.5(b)(1)(A))
- Removes the criminal penalties for cultivation and possession of marijuana by qualified patients, who are persons with a physician’s written or oral recommendation or approval to use marijuana for medical use, or by their primary caregivers, and protects physicians from punishment for recommending marijuana to a patient for medical purposes. (HSC § 11362.5(d) and (e))
- Specifies that participation in the Medical Marijuana Program shall not authorize a qualified patient to engage in the smoking of medical marijuana under any of the following circumstances:
- In any place where smoking is prohibited by law;
- In or within 1,000 feet of the grounds of a school, recreation center, or youth center, unless the medical use occurs within a residence;
- On a school bus;
- While in a motor vehicle that is being operated; or
- While operating a boat. (HSC § 11362.79)
- Specifies that, except as authorized by law, a person 18 years of age or older who possesses not more than 28.5 grams of cannabis, or not more than eight grams of concentrated cannabis, upon the grounds of, or within, any school providing instruction in kindergarten or any of grades 1 to 12, inclusive, during hours the school is open for classes or school-related programs is guilty of a misdemeanor and shall be punished as follows:
- A fine of not more than two hundred fifty dollars ($250), upon a finding that a first offense has been committed.
- A fine of not more than five hundred dollars ($500), or by imprisonment in a county jail for a period of not more than 10 days, or both, upon a finding that a second or subsequent offense has been committed. (HSC § 11357(c))
- Specifies that person 18 years of age or over who:
- Hires, employs, or uses a minor in unlawfully transporting, carrying, selling, giving away, preparing for sale, or peddling any cannabis, who unlawfully sells, or offers to sell, any cannabis to a minor, or who furnishes, administers, or gives, or offers to furnish, administer, or give any cannabis to a minor under 14 years of age, or who induces a minor to use cannabis in violation of law shall be punished by imprisonment in the state prison for a period of three, five, or seven years.
- Furnishes, administers, or gives, or offers to furnish, administer, or give, any cannabis to a minor 14 years of age or older in violation of law shall be punished by imprisonment in the state prison for a period of three, four, or five years.
ANALYSIS
This bill, known as Jojo’s Act, authorizes the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt a policy that allows a parent or guardian of a pupil to possess and administer non-smokeable and non-vapeable medicinal cannabis to the authorized pupil at a schoolsite. Specifically, this bill:
- Authorizes, notwithstanding state law identified in (4) and (5) above, the governing board of a school district, a county board of education, or the governing body of a charter school maintaining kindergarten or any of grades 1 to 12, inclusive, to adopt, at a regularly scheduled meeting of the governing board or body, a policy that allows a parent or guardian of a pupil to possess and administer to the pupil who is a qualified patient pursuant to Medicinal Marijuana Program.
- Requires the adopted policy to include at least all of the following elements:
- A prohibition against a parent or guardian from administering medicinal cannabis in a manner that creates a disruption to the educational environment or causes exposure to other pupils.
- A requirement for the parent or guardian to remove any remaining cannabis from the schoolsite after the parent or guardian administers the medicinal cannabis.
- A requirement for the parent or guardian to sign in at the schoolsite before administering the medicinal cannabis.
- A requirement that before administering the medicinal cannabis, the parent or guardian must provide to an employee of the school a valid written medical recommendation for medicinal cannabis for the pupil to be kept on file at the school.
- Provides the following with regards to the pupil records collected in accordance with the adopted policy for the administration of medicinal cannabis to a pupil:
- Specifies that the records are confidential.
- Requires the records be used only for the purpose of administration of medicinal cannabis to the pupil.
- Prohibits the records from being open to the public for inspection or disclosed for any reason, except as required by a state or federal court order.
- States Legislative findings and declarations that the provisions in (a) to (c) impose a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution, and that pursuant to that constitutional provision, that the Legislature finds, to demonstrate the interest protected by this limitation and the need for protecting that interest, that in order to protect the privacy of pupils, and parents and guardians of pupils, who are administered medicinal cannabis, it is necessary that pupil records collected for the purpose of administration of medicinal cannabis be confidential.
- Authorizes the governing board of a school district, a county board of education, or the governing body of a charter school to rescind the policy at a regularly scheduled meeting of the governing board or body for any reason, including, but not limited to, if the school district, county office of education, or charter school is at risk of, or has lost, federal funding as a result of the policy.
- Specifies that none of the bill’s provisions require the staff of a school district, county office of education, or charter school to administer medicinal cannabis.
- Prohibits medicinal cannabis in a smokeable or vapeable form for purposes of the bill.
STAFF COMMENTS
- Need for the bill. Accord to the author, “Some students need medical cannabis to be able to attend school and have normal childhood experiences. Currently, these students must be picked up by their parents and taken off campus in order to take their medicine. This is disruptive to their learning. Every child is entitled to an uninterrupted education. The Compassionate Use Act of 1996 (Proposition 215) allows minors to use medical cannabis with the consent of their parents and a recommendation from a doctor… Many of these minors need to take a dose of medical cannabis at regular intervals, which often includes during school hours. Current law does not allow any form of cannabis on school grounds. Existing law allows schools to legally administer any pharmaceutical drug, including opioids, that a child has been prescribed. But there are medical conditions pharmaceuticals can’t fix, and they often have debilitating side effects. Medical cannabis helps fill some of these gaps, and lessen these challenging side effects.”
- Potential for medical benefits from medicinal cannabis. The federal government classifies cannabis as a Schedule I drug, which indicates that the federal government does not recognize any currently accepted medical use in treatment in the United States. However, at least one study indicates medicinal cannabis may be particularly effective in treating Lennox-Gastaut syndrome, a rare, severe form of epileptic encephalopathy. A randomized, double-blind, placebo-controlled trial published in The Lancet found that “add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syndrome and is generally well tolerated.”
On July 25, 2018, The United States Food and Drug Administration (FDA) approved Epidiolex, the drug used in the trial published in The Lancet, as an oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. According to the FDA, “it is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA-approval of a drug for the treatment of patients with Dravet syndrome.” In its announcement of the approval, the FDA stated that “Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo.”
- Other states have recently approved similar measures. In 1996, California became the first state to approve medical marijuana. According to the National Conference of State Legislators, since then, an additional 28 states, the District of Colombia, Guam, and Puerto Rico have followed suit and now allow for comprehensive public medical marijuana programs. An additional 17 states allow the use of “low THC, high cannabidiol (CBD)” for medical reasons or as a legal defense.
More recently, five of the 29 states with comprehensive medical marijuana programs: Washington, Colorado, Florida, Maine, and New Jersey have enacted laws authorizing students to use medical cannabis on school campuses. According to the Education Commission of the States, “While it is too soon to identify specific trends in policies, both New Jersey and Colorado require that:
- Students using medicinal marijuana products have a valid medical recommendation.
- Only non-smokable marijuana products may be administered on school grounds.
- Only parents, legal guardians or primary caregivers administer the substance.
d) Students cannot be punished for marijuana use on school grounds.”
Maine’s law differs from those states because policymakers worked from the state’s existing medical marijuana framework and simply expanded the locations in which medical marijuana use is permissible. Alternatively, Washington has taken a slightly different path and instead specifies that schools are not required to permit on-site use of medical marijuana, but are permitted to allow it if they choose. Conversely, Florida requires each district school board to adopt a policy and procedure.
Additionally, New Mexico’s legislature has introduced legislation this session, Senate Bill 204, to authorize students to received medicinal marijuana on school campuses. As of March 11, 2019, the bill has passed both houses of the New Mexico legislature.
Here, this bill strikes an appropriate balance between these different approaches, mimicking Washington’s opt-in approach but prescribing some uniform conditions like Colorado and New Jersey, such as only authorizing non-smokeable, non-vapeable products and only authorizing parents and legal guardians.
- Federal funding risk? In 2018-19, California received approximately $8.2 billion in federal funding for schools. Federal grants are subject to federal regulations implementing drug-free workplace requirements. Noncompliance with those requirements could result in the loss of federal funding, as grantees and sub-grantees must make a “good faith effort” to maintain a drug-free workplace as a condition of the grant award. A drug-free workplace includes any location where the performance of work is done in connection with a specific award, which could include school buildings in Title I schools and schools that participate in federal programs such as National School Lunch Program or School Breakfast Program. Importantly, federal agencies have discretion in determining whether a grantee or sub-grantee is in violation of the drug-free workplace requirements, and have a range of options to compel compliance. When the Colorado Legislative Council Staff analyzed this issue for their state, it assumed “that withholding federal funds is the last and most extreme action the federal government can take, and that any conflict between state laws and federal rules can be addressed without forfeit of federal grants and other distributions.” Moreover, this bill specifically allows for any local educational agency that has adopted a policy to allow parents or guardians to administer appropriate medicinal cannabis to rescind that policy for any reason, including the risk of losing funding.
- Previous legislation. SB 1127 (Hill, 2018) was identical to this bill and was vetoed by Governor Brown, who stated:
“This bill is overly broad as it applies to all students instead of limited cases where a doctor recommends medical marijuana for a student in order to prevent or reduce the effects of a seizure. Generally, I remain concerned about the exposure of marijuana on youth and am dubious of its use for youth for all ailments. This bill goes too far -- further than some research has -- to allow use of medical marijuana for youth. I think we should pause before going much further down this path.”
This identical bill does not address the concerns raised by Governor Brown. While there is a new governor, the committee may wish to consider whether a new governor is a sufficient reason to pass recently vetoed legislation.
SB 1266 (Huff, Chapter 321, Statutes of 2014) requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered, as specified. Authorizes school nurses or trained personnel to use the epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
SB 1051 (Huff, 2010) would have authorized a school district, until January 1, 2016, to provide nonlicensed school employees with voluntary training for the provision of emergency medical assistance to a pupil suffering from an epileptic seizure, in the absence of licensed personnel. SB 1051 died in the Senate Appropriations Committee.
AB 1430 (Swanson, 2009) would have provided that only a credentialed school nurse may administer medication to pupils, but did specifically allow non-medical school personnel to administer epinephrine via auto-injector and insulin in cases of an emergency. AB 1430 was never heard.
SUPPORT
Americans for Safe Access
California Cannabis Industry Association
California NORML
California School Boards Association
CannaKids
Rincon Valley Union School District
Southern California Coalition
Numerous individuals
OPPOSITION
None received
-- END --
Bill Author
Bill Co-Author(s):